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ABSTRACT 
Electromembrane extraction (EME) was described for the first time in 2006 and demonstrated 
electrokinetic migration of charged substances from an aqueous sample solution through a 
supported liquid membrane (SLM) and into an aqueous acceptor solution. EME was reported 
as a selective and fast extraction technique providing clean extracts from biological samples 
that are directly compatible with analytical instrumentation. The intention of this thesis was to 
investigate fundamental aspects of EME and to further develop technical EME configurations. 
Major focus was on extraction of small molecular substances from human matrices; extraction 
at low voltages (<10 V), short extraction times (<10 min), exhaustive extraction, and parallel 
extractions of multiple samples.  
In Paper I a portable EME device was developed, this device was operated under stagnant 
conditions with a 9 V battery as power supply. Amitriptyline, citalopram, fluoxetine, and 
fluvoxamine were isolated electrokinetically from 70 μL undiluted human plasma and into 30 
μL of 10 mM HCOOH. The final extract was analyzed by liquid chromatography coupled to 
mass spectrometry (LC-MS). Extraction time, extraction voltage, SLM, and acceptor solution 
were optimized in terms of extraction recovery. This EME setup provided extraction 
recoveries in the range 12-22% after 1 min of extraction. Although the extraction recoveries 
were relatively low, the combination of EME with LC-MS provided lower limit of 
quantification (LLOQ) below the therapeutic range. The r2 in the therapeutic range (1-1000 
ng mL-1) was above 0.998 for all analytes. In addition, the sample throughput was increased 
by operating three sample compartments in parallel with a single 9 V battery.  
In Paper II the extraction recovery with EME was investigated by introducing three separate 
hollow fibers into a single sample compartment. This setup provided exhaustive EME of 
citalopram, loperamide, methadone, paroxetine, pethidine, and sertraline from pH adjusted 
water samples. The three-fiber configuration was also utilized to isolate the same basic 
analytes from untreated human plasma samples. However, the extraction recoveries were 
reduced to some extent regarding some of the analytes; probably due to proteinbinding in 
human plasma and thus limited transportation of the analytes through the SLM. The setup was 
evaluated regarding linearity, reproducibility, and LLOQ, and the results were considered as 
acceptable in terms of regulatory guidelines. The three fiber approach in combination with 
LC-MS was used to isolate citalopram from two patient plasma samples; the reported plasma 
concentration deviated less than 14% compared to data obtained by a reference laboratory.    
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In Paper III EME was evaluated with samples of human whole blood spiked with the 
following drugs of abuse: Cathinone, 2,5-dimethoxy-4-iodoamphetamine (DOI), 
methamphetamine, 3,4-methylendioxy-amphetamine (MDA), 3,4-methylendioxy-
metamphetamine (MDMA), and ketamine. Extraction time, SLM composition, acceptor 
solution, and extraction voltage were all optimized regarding extraction recovery. The final 
setup isolated the analytes of interest from 80 μL sample, through an SLM consisting of 1-
ethyl-4-nitrobenzene (ENB), and further into 10 μL of acetic acid, the applied voltage was 15 
V, and the extraction was performed for 5 min. The final EME-configuration with a 15 V 
battery as power supply was utilized to isolate cathinone, amphetamine, methamphetamine, 
ketamine, MDA, and MDMA from autenthic forensic samples. Although the extraction 
recovery was in the range 10-30%, the combination of EME with ultra performance liquid 
chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) provided LLOQ 
below the concentrations associated with drug abuse.  
In Paper IV the approach from paper II was combined with solid sampling of biological 
samples on sheets of alginate- and chitosan foam. Samples of 10 μL whole blood spiked with 
citalopram, loperamide, methadone, and sertraline were spotted on sheets of either alginate- 
and chitosan foam and thereafter dried for 2 hours. Subsequently, the dried blood spots (DBS) 
were punched out and disintegrated in 300 μL HCl for 3 min. From this solution the analytes 
of interest were isolated by EME into 20 μL of 20 mM HCOOH, and provided extracts 
directly compatible with LC-MS analysis within 10 min. In addition, the novel approach was 
compared with DBS sampling on well-established sampling media like Whatman FTA 
DMPK-A and Agilent Bond Elut DMS. The elution recoveries reported with those media was 
inferior compared to sampling on alginate- and chitosan foam and subsequent extraction with 
EME. The absence of interfering matrix componentes in the final EME extract was also 
demonstrated in Paper IV  
In Paper V samples of oral fluid was spotted on alginate- and chitosan foam. 10 μL of oral 
fluid spiked with buprenorphine, methadone, methamphetamine, para-methoxy-amphetamine 
(PMA), and para-methoxy-metamphetamine (PMMA) was applied to alginate- and chitosan 
foam; subsequently the dried spots were punched out and disintegrated in 300 μL 1 mM HCl 
for 5 min. The analytes were subsequently isolated from this solution by EME and into 0.1% 
trifluoracetic acid (TFA) within 5 min. The experimental conditions were optimized. The final 
setup was evaluated regarding linearity in the relevant concentration range, RSD, extraction 
recovery, and storage-stability for 30 days. The evaluation results were considered as 
PhD thesis Lars Erik Eng Eibak  ABSTRACT 
7 
 
acceptable with regards to regulatory guidelines. Post-column infusion experiments 
demonstrated that the final EME extract was free from interfering matrix components and 
underlined the sample cleanup provided with EME.  
In Paper VI EME was introduced into the multi-well platform with flat membranes to enable 
parallel extractions with EME; this approach increased the overall sample throughput with 
EME. The idea of parallel electromembrane extraction (Pa-EME) with the hollow fiber 
configuration was briefly investigated in Paper I; however this setup was highly challenging 
to operate. In Paper VI amitriptyline, fluoxetine, quetiapine, and sertraline were isolated from 
eight plasma samples into eight separate extracts of 70 μL 20 mM HCOOH. The experimental 
conditions were optimized with a Quality by Design (QbD), and were as follows: Extraction 
time 8 min, extraction voltage 200 V, sample volume 240 μL, acceptor volume 70 μL, and 
agitation rate 1040 rpm. The linear calibration curves in the therapeutic range were above 
0.9974; this calibration curve was used to quantify plasma concentrations of quetiapine and 
sertraline in patient samples. Additionally, post-column infusion experiments demonstrated 
the sample cleanup provided with Pa-EME.      
In Paper VII the Pa-EME performance was investigated with different matrices to establish 
how the Pa-EME was affected by small, but deliberate variations in method parameters during 
normal use. Urine, human plasma, and pH adjusted water samples were utilized as sample 
matrices. The Pa-EME system was also stressed by perforating one or several of the wells in 
order to investigate how this influenced the remaining intact wells in the multi-well plate. The 
total number of samples processed simultaneously was increased from eight in Paper VI to 68 
and finally 96 samples in Paper VII. Paper VII demonstrated for the first time extraction of 96 
samples simultaneously with EME. The combination of a robust high-throughput sample 
preparation technique with UPLC-MS/MS provided a powerful platform for analysis of small 
molecular drug substances from biological matrices.  
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1. INTRODUCTION  
The overall objective of analytical chemistry is to accurately detect and quantitate the analyte 
of interest from a sample; however the majority of the sample matrices available for this 
purpose are not directly compatible with analytical instrumentation. Biological, environmental, 
and food samples include several contaminants which normally are present in high 
concentrations and could interfere with the final analysis. Consequently, a sample preparation 
procedure is vital to isolate the analytes from the sample and into a solution compatible with 
the analytical instrumentation. This sample preparation step is considered as the “bottleneck” 
of the bioanalytical workflow, and the time consumption is estimated to around 75% of the 
total time [1-3]. Sample preparation is often a compromise between time, sample cleanup, and 
complexity of the procedure. The search for novel, more environmental- and user friendly 
sample preparation techniques to solve exisiting and novel analytical challenges is dynamic 
and continuous. 
1.1 Sample preparation in bioanalysis 
Traditionally, whole blood, plasma, serum, and urine have been the key matrices for 
determination of the concentration of small molecular substances in bioanalysis [4]. The 
abovementioned matrices are incompatible with immediate analysis and a sample preparation 
step prior to analysis is considered as mandatory [1, 2, 5, 6]. This is mainly due to the 
numerous interfering endogenous compounds like proteins, salts, lipids, and cells found at 
high concentrations in such biological matrices. An optimal sample preparation should 
provide extracts compatible with analytical instrumentation with low consumption of 
hazardous chemicals and contribute to a reliable detection and quantitation.  
Traditionally, liquid-liquid extraction (LLE), protein precipitation (PP), and solid-phase 
extraction (SPE) have been the selected sample preparation techniques in bioanalytical routine 
laboratories [7]. The aforementioned sample preparation techniques are based on well-known 
principles and numerous applications have been published. However, those techniques are 
associated with large consumption of sample volume, extraction phase, and organic solvents. 
A large ratio between extraction phase and sample increase the extraction recovery and this 
approach has been mandatory with the analytical instrumentation available in the past. 
However, a large extraction phase dilutes the analyte to a significant degree [1, 7]. 
Consequently, the final extract has to be evaporated to dryness and reconstituted in a proper 
solvent in order to limit both the dilution of the analyte and reduce the solvent strength prior 
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to injection into the analytical instrumentation. The evaporation step could be time consuming, 
especially if the final extract consists of a low-volatile solvent.  
1.2 Microextraction techniques 
In the early 1990s a shift was observed in the sample preparation field; the sample volume 
required to quantitate small molecular substances was reduced from milliliter to microliter [8, 
9]. The primary contributor to this development was the increased sensitivity provided with 
the analytical instrumentation; the improved sensitivity also eliminated the requirement for 
exhaustive extractions. Solid-phase microextraction (SPME) was introduced as the first 
microextraction technique in 1990 [10]. SPME is considered as a “soft” extraction technique, 
which means that only a small fraction of the analyte is isolated from the sample. The 
commercially available device introduced by Supelco [11, 12] has contributed to the interest 
and the number of papers concerning SPME in the literature. At the same time existing 
sample preparation techniques were refined in the same direction inspired by the development 
of SPME [7]. 
1.2.1 Single drop microextraction (SDME) 
Single drop microextraction was introduced in 1996 by Liu and Dasgupta [13]; in this 
approach a drop of a water immiscible organic solvent was suspended in a larger aqueous 
drop. The outer aqueous drop contained the analytes of interest and diffused into the organic 
drop. After extraction the organic drop was aspirated with a syringe and the analyte 
concentration was related to absorbance with a light-emitting-diode-based absorbance 
detector. Jeannot and Cantwell [14] presented another SDME approach at the same time; in 
this setup the water immiscible organic solvent was attached to a microsyringe and immersed 
into an aqueous sample solution as presented in Fig. 1-1a [15]. The analytes of interest 
diffused from the aqueous sample and into the organic drop; thereafter the organic droplet 
was aspirated into the microsyringe and injected directly into a gas chromatograph (GC). The 
idea of both SDME-approaches was to reduce the consumption of hazardous organic solvents 
to a minimum compared to conventional LLE. The pH value in the sample was strictly 
controlled to ensure that the analytes present in the aqueous sample solution were unionized 
in order to facilitate the partition into the organic liquid. A magnetic stirrer induced mixing of 
the aqueous sample solution and facilitated diffusion of the analyte into the organic drop.  
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In headspace SDME the organic drop is located just above the sample solution [16-20] as 
presented in Fig. 1-1b [15]. The direct compatibility of the organic drop with GC in the 2-
phase SDME led to the investigation of a 3-phase SDME approach with an aqueous sample 
solution, an organic liquid, and an aqueous droplet as presented in Fig. 1-1c [15]. The analytes 
of interest in the sample are unionized in order to facilitate diffusion into the organic liquid, 
and the aqueous drop is pH-adjusted to facilitate diffusion in the interface from the organic 
liquid and into this aqueous receiver drop. Subsequently, the drop is aspirated and analyzed 
with high performance liquid chromatography (HPLC). 
 
 
SDME provides high enrichment factors due to the ratio between sample (1-5 mL) and the 
organic drop (1-50 μL); enrichment factors up to 500 have been reported with 3-phase SDME 
[21] within a relatively short period of time (1-20 min) [22]. SDME is also considered as an 
environmental-friendly sample preparation technique due to the low consumption of organic 
liquid (1-50 μL).  
The consumption of organic solvent is reduced substantially compared to conventional LLE. 
The simple equipment needed for SDME, low cost per extraction, ease of operation, and the 
compatibility with liquid- or gas chromatography is considered as advantages compared to 
other extraction techniques [9, 23]. However, extensive stirring in the sample solution 
promotes dislodging of the drop from the microsyringe tip and into the sample solution. 
Fig. 1-1. Single drop microextraction in 2-phase mode (a), head-space mode (b), and 3-phase mode
(c), respectively. (Reprinted with permission from [15] © 2009 Future Science Group)   
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Another issue is the emulsifying properties of biological fluids like blood and plasma; this 
emulsification could reduce the drop-stability. Consequently, SDME is considered as less 
compatible sample preparation technique in combination with biological fluids compared to 
pH adjusted water samples. 
1.2.2 Supported liquid membranes (SLM)  
The instability of the single organic drop and furthermore lack of robustness reported with the 
SDME configuration increased the interest for supported liquid membranes in the field of 
sample preparation. The idea of using SLM for sample preparation in bioanalysis was 
introduced by Audunsson already in 1986 [24], and the interest for SLM reemerged in the late 
1990s [25-30]. In SLM extractions the sample- (donor) and extraction (acceptor) solution is 
separated by an organic liquid sustained by capillary forces in the pores of a hydrophobic 
supporting material as presented in Fig. 1-2 [24, 31]. The aim of the SLM extraction is to 
isolate the analytes of interest from the donor solution, through the SLM, and into an aqueous 
acceptor solution. The diffusion is facilitated by pH-gradients. Unionized analytes diffuse 
passively from the donor solution and into the organic liquid sustained in the pores of the 
SLM. Subsequently, the analytes are ionized upon contact with the pH-adjusted acceptor 
solution. Sufficient contact in the interfaces between the donor solution, the SLM, and the 
acceptor solution are mandatory to isolate the analytes efficiently from the donor solution and  
 
into the acceptor solution. The donor solution is pumped continuously with a syringe pump 
through the donor chamber and the analytes diffuse passively into the SLM and further into to 
the stagnant acceptor solution. Typical extraction time for SLM extractions with the flat 
membrane configuration is 10-20 min. SLM extractions provides decent sample cleanup from 
biological matrices like plasma, whole blood, and urine [24-26, 28, 32, 33]. 
Fig. 1-2. Principle of supported liquid membrane extraction (SLM). (Reprinted with permission from 
[25]. ©1999 Elsevier) 
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Another configuration is the device with two chambers to continuously deliver both donor and 
acceptor solution to increase the extraction efficiency [26, 28, 33]. The need for syringe 
pumps to continuously deliver both donor- and acceptor solution requires a relatively complex 
apparatus and is considered as a drawback. Also the long-term stability of the reuseable 
supporting material is a potential problem.  
1.2.3 Liquid-phase microextraction (LPME) and parallel artificial liquid 
membrane extraction (PALME) 
The instability of the single drop reported with SDME and the complex instrumentation with 
SLM was addressed in 1999 [34]. In this approach the organic liquid was applied to a 
supporting material comparable to SLM extractions; however in this setup the supporting 
material was a hollow polypropylene fiber [34]. The hollow fiber based liquid phase 
microextraction (HF-LPME) was described for the first time by Pedersen-Bjergaard and 
Rasmussen. The idea of LPME is diffusion of neutral analytes from a sample, into an organic 
liquid sustained in the pores of a supporting material, and further back-extracted as ionized 
species into an acceptor solution inside the hollow fiber. The acceptor solution is directly 
compatible with analytical instrumentation without the need for evaporation and 
reconstitution. LPME could be operated either in 2- or 3-phase mode. In the 2-phase mode the 
donor solution is aqueous and both the SLM and the acceptor solution inside the hollow fiber 
is an organic liquid. The 2-phase mode provides extracts directly compatible with GC [35, 36]. 
In the 3-phase mode the donor solution is aqueous, the SLM consists of an organic liquid, and 
the acceptor solution is aqueous and directly compatible with HPLC [37, 38]. This technique 
has obtained a widespread interest worldwide although HF-LPME has been difficult to 
incorporate into fully automated liquid handling systems. The HF-LPME configuration is 
presented in Fig. 1-3 [39].  
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In order to enable the incorporation of LPME into liquid handling systems a novel LPME 
setup with flat membranes was introduced by Gjelstad et.al in 2013 [40]. In this setup, named 
PALME, the supporting material was a flat polypropylene membrane. The organic liquid was 
sustained in the pores of this flat membrane, and the acceptor solution was filled in the multi-
well plate. The donor solution was added to a 96 well plate. This setup is presented in Fig. 1-4. 
The analytes diffused passively from the sample solution into the SLM and further into the 
acceptor solution under agitation [40]. Thereafter the acceptor solution was analyzed with 
liquid chromatography combined with mass spectrometry (LC-MS). The altered geometry in 
the flat membrane configuration compared to hollow fiber LPME increased the acceptor 
volume reservoirs. This setup provided simultaneous isolation, and enrichment of analytes 
from a multiple number of samples within 30 min of extraction [40]. This setup could most 
probably be incorporated into liquid handling systems for increased throughput in the near 
future.  
Fig. 1-3. Illustration of liquid phase microextraction (LPME). (Reprinted with permission from [39].
© 2013 Future Science Group) 
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1.3 Electro enhanced extractions 
The migration of charged species across a liquid-liquid interface under the application of an 
electrical field is well-known and provides an interesting tool for tuning the extraction 
selectivity [41-44]. The rationale for applying an electrical field is to increase the extraction 
kinetics and thus reduce the extraction time.  
Van der Vlies et.al introduced an idea of combining liquid-liquid extraction with 
isotachophoresis and capillary zone electrophoresis [45-47]. This approach was conducted in 
a capillary electrophoresis system. A leading buffer was filled in the fused-silica capillary, 
thereafter an acceptor phase was introduced into the capillary inlet, the capillary inlet and the 
anode was located in an organic solvent containing cationic analytes. The capillary outlet and 
the cathode were placed in a vial with leading buffer. The application of an electrical field in 
such a system facilitated the migration of cationic species from the organic solvent and into 
the capillary inlet. In another approach the application of an electrical field (dc) in the 
interface between two immiscible electrolyte solutions (ITIES) was investigated by Berduque 
et.al in 2005 [48]. The application of an electrical field in ITIES extractions created an 
increased positive donor solution relative to the acceptor solution; this facilitated the transfer 
of cationic species from the donor- and into the acceptor solution.  
Very recently Raterink et.al described another electroextraction approach [49]. A single drop 
of acceptor solution was attached to a conductive pipette tip and immersed into a donor 
Fig. 1-4. Shematic illustration of a Parallel artificial liquid membrane extraction (PALME) setup. 
(Reprinted with permission from [40]. © 2013 Future Science Group) 
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solution where the electrode with opposite charge was located. After immersion into the 
donor solution an electrical field was applied and enabled electrokinetic migration of seven 
different carnitines from the donor solution and into the hanging drop. After extraction the 
drop was injected directly into a nano ESI-MS system for analysis [49].  
1.4 Electromembrane extraction (EME) 
Electromembrane extraction was described by Pedersen Bjergaard and Rasmussen in 2006 
[50]; EME was a combination of LPME and more traditional electro enhanced extractions [41, 
42, 44-48, 51-54]. By applying an electrical field (dc) in the LPME setup it was shown that 
the time needed to reach steady-state was reduced [55]; this time reduction has been assumed 
to be a result of the applied electrical field. In EME the sample solution is filled into the 
sample compartment and an electrode is placed in this solution; a porous polypropylene 
hollow fiber is impregnated for a given time with an organic liquid, the excess organic liquid 
is gently removed by a medical wipe. This impregnated hollow fiber serves as the SLM; and 
is subsequently filled with an acceptor solution before 
another electrode is placed in the lumen of the hollow fiber. Both the anode and cathode are  
 
 
connected to an adjustable power supply and an electrical field (dc) is applied for a certain 
period of time [50]. An EME setup is presented in Fig. 1-5. The direction of the electrical 
field is dependent on whether anions or cations should be isolated from the sample solution 
and into the acceptor solution. The extraction compartment is placed on a shaking board, and 
Fig. 1-5. Schematic illustration of an electromembrane extraction (EME) setup. (Reprinted with
permission from Paper V. © 2013 Future Science Group) 
PhD thesis Lars Erik Eng Eibak  1. INTRODUCTION 
16 
 
the extraction is typically continued for 5 min [56-59]. After extraction the acceptor solution 
is collected by a microsyringe and transferred to an analytical instrumentation (LC or CE) for 
the final analysis.   
1.4.1 Principle 
The theoretical description of EME is complex due to both diffusion- and electrokinetic 
components of mass transfer. Firstly, the analytes diffuses into the SLM; secondly the 
analytes are transported electrokinetically as ionized species from the SLM and into the 
acceptor solution. The pH of the acceptor solution prevents the ionized analytes to be back-
extracted into the sample solution. The time reduction observed with EME compared to 
LPME is mainly due to the electrokinetic transportation from the SLM and into the acceptor 
solution [60]. The theoretical considerations are based upon the Nernst-Planck equation and 
assume that the SLM is electrically neutral and is valid for thick membranes (200 μm) [61]. 
ܬ௝ ൌ െܦ௝ ௗ௖ೕௗ௫ ൅
஽ೕ௭ೕ௘ா௖ೕ
௞்          (1) 
Eq. (1) describes the steady-state flux ሺܬ௝ሻ of an ionic substance across the SLM and the flux 
is dependent on the diffusion coefficientሺܦ௝), its charge (ݖ௝), the concentration of the analyte 
in the SLM (ܿj), the distance between the analyte and the SLM/acceptor solution interfaceሺݔሻ, 
the Boltzmann`s constant (݇), the elementary charge (e), the electrical field (E), and the 
absolute temperature (T). The first term in Eq. (1) describes the diffusion of the analyte from 
the sample and into the SLM, and the latter term describes the electro-migration. However, 
the assumptions in Eq. (1) are not valid for thinner membranes and when there is a difference 
between the ion concentrations in the donor solution compared to the acceptor solution, which 
is the most frequent situation in EME. The steady-state flux of a singly charged cationic 
substance (ܬ௜ሻ across an uncharged membrane can therefore be described by Eq. (2). 
ܬ௜ ൌ  ି஽೔௛ ቀͳ ൅
௩
୪୬஧ቁቀ
஧ିଵ
஧ିୣ୶୮ሺି௩ሻቁ ሺܿ௜௛ െܿ௜଴ሺെݒሻሻ     (2) 
The steady-state flux is dependent on the diffusion coefficientሺܦ௜ ), the thickness of the 
membraneሺ݄ሻ, a dimensionless driving force (v) defined by Eq. (3) including the potential 
difference across the SLM ሺοᢥሻ, the ratio of the total ion concentration on the sample side to 
that on the acceptor solution (ɖ ) is described by Eq. (4), the ratio of the total ionic 
concentration in the sample ሺܿ௜௛ሻ to that in the acceptor solutionሺܿ௜௢).   
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ݒ ൌ  ௭೔௘οᢥ௞்            (3) 
ɖ ൌ  ఀ೔಴೔೓ାఀೖ಴כೖ೓ఀ೔಴೔బାఀೖ಴כೖబ          (4) 
For a given EME setup the thickness of the SLM and the diffusion coefficient for a given 
analyte would be constant. Thus, the flux across the SLM can be improved either by 
increasing the potential difference across the SLM or by reducing the ion balance over the 
SLM.  
1.4.2 Extraction time  
Electromembrane extraction is a refined LPME-approach with an electrical field and the 
extraction time is typically reduced from 45 min in LPME to 5 min with EME [62]. This time 
reduction is ascribed to the applied electrical field (dc) and the short time to reach steady-state 
is considered as an important advantage with EME compared to other extraction techniques. 
In EME it is desireable to continue the extraction until steady-state has been reached; which is 
typically 5 min as presented in Fig. 1-6 [63]. In the kinetic region of the EME a relatively 
small difference in extraction time could potentially affect the extraction recovery 
significantly. The final EME-extract is directly compatible with final analysis, for instance by 
HPLC, LC-MS, or capillary electrophoresis (CE).  
 
 
1.4.3 Supported liquid membrane    
The supported liquid membrane in EME is made by impregnating the pores of the supporting 
material with an organic liquid. The objective of the SLM is to separate the sample solution 
from the acceptor solution. Another feature of the SLM is to serve as the resistance in the 
electrical circuit in the EME setup, and an adequate SLM-stability of the organic liquid in the 
pores of the supporting material is mandatory to prevent electrolysis [55, 62, 64-66]. It is well 
Fig. 1-6. Extraction recovery (%) as function of extraction time for pethidine, nortriptyline, 
methadone, haloperidol, and loperamide. (Reprinted with permission from[63].© 2008 Elsevier)  
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known that different organic liquids exert different stability in the supporting material. EME 
setups with organic liquids which are to soluble in either the the sample- or acceptor solution 
would reduce the resistance and consequently increase the flow of current in the system [66]. 
The loss of resistance in the SLM will further promote electrolysis in both the sample- and 
acceptor solution. An optimal organic liquid in EME should be non-volatile, low viscous, and 
immiscible with both sample- and acceptor solution [64]. A wide range of organic liquids 
with various physical-chemical properties have been investigated as SLM in EME [66]. 2-
Nitrophenyl octylether (NPOE) is the most thorough investigated organic liquid and 
extraction recoveries up to 80% have been reported with non-polar basic drugs as analytes by 
combining NPOE as SLM with extraction voltages up to 300 V [64]. 1-Ethyl-4-nitrobenzene 
(ENB) and 1-Isopropyl-4-nitrobenzene (IPNB) provides similiar extraction recoveries with 
only 20 V as applied voltage [57, 58, 67]. Increased extraction voltage with ENB and IPNB 
would increase the flow of current due to their higher aqueous solubility compared to NPOE.  
In order to facilitate the distribution of more hydrophilic (log P<1) analytes into the SLM a 
carrier molecule has been added to the organic liquid prior to impregnation of the supporting 
material. This approach increased the hydrophobicity of the analyte and thus the affinity for 
the SLM; the analyte is released from the carrier molecule upon contact with the acceptor 
solution. This approach has been utilized for isolation of peptides with SLM extractions [68-
70]. The same idea was used to increase the extraction recoveries of more hydrophilic basic 
drugs [64] and peptides in EME [71-73]. It was shown that the isolation of more hydrophilic 
basic drugs was more efficient by addition of carrier molecules. Cimetidine, a drug with log P 
of 0.4, was not detected in the acceptor solution with pure NPOE as SLM; however by adding 
25% (w/w) di (2-etylhexyl) phosphate (DEHP) to NPOE prior to impregnation of the 
supporting material the extraction recovery was increased up to 75% [64].    
1.4.4 Extraction voltage 
The flexibility provided with an external power supply in EME provides a unique opportunity 
to selectively isolate the analyte of interest from the sample- and into the acceptor solution. 
Both the direction- and the magnitude of the applied electrical field in the EME-setup are 
easily altered. The direction of the electrical field is dependent on the type of ionic substances 
to be isolated into the acceptor solution; for the isolation of anions the anode is located in 
acceptor solution and for the isolation of cations the cathode is placed in the acceptor solution 
[50, 74]. The magnitude is easily adjusted with the power supply; however the magnitude of 
the applied electrical field is highly dependent on the stability of the SLM in the supporting 
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material [66, 75]. Instable SLMs would dissolve into the sample- and/or acceptor solution. 
Consequently, an extensive flow of current would be observed. This flow of current would 
promote electrolysis and alter the pH-value both in the sample- and acceptor solution 
according to the following reactions: 
ܦ݋݊݋ݎݏ݋݈ݑݐ݅݋݊ǣܪଶܱ ՜ ʹܪା ൅ଵଶܱଶ ൅ʹ݁ି  
ܣܿܿ݁݌ݐ݋ݎݏ݋݈ݑݐ݅݋݊ǣʹܪା ൅ʹ݁ି ՜ ܪଶ  
In a paper from 2008 the adjustable power supply, which has been utilized in the majority of 
the EME papers [50, 55, 61, 62, 64, 71-74, 76-83], was replaced by a 9 V battery [63]. The 
flexibility regarding tuning the extraction voltage was lost; however this paper demonstrated a 
simple and portable EME setup.   
1.4.5 Sample solution  
According to Eq. (2) a reduction of the ionic strength in the sample solution to the ionic 
strength in the acceptor solution (low χ) increase the flux across the SLM [61]. Increased 
ionic strength in the sample solution provides increased current flow and electrolysis both in 
the sample- and acceptor solution. The electrolysis, especially in the acceptor solution would 
increase the pH-value and consequently reduce the back-extraction into the acceptor solution. 
The least complex sample solution in EME is a pH adjusted water sample spiked with the 
analytes of interest; most of the EME publications in the literature have used pH adjusted 
water samples as sample solution. Nevertheless, in bioanalysis the used sample matrices to 
detect and quantiate drug substances are whole blood, plasma, serum, and urine, and oral fluid. 
The pH value of those matrices is strictly controlled endogenously; the pH of whole blood, 
serum, and plasma is 7.4. The pH-value of urine and oral fluid fluctuate more, and is highly 
dependent on food- and beverage intake [84, 85]. In order to ensure sufficient ionization of 
the drug substances in any sample solution the pH-value should be two units below and above 
the pKa-value for basic- and acidic substances, respectively. The physiological pH-value of 
7.4 provides a sufficient ionization of strong bases without manipulation of the sample and 
EME can thus be performed directly from those matrices [78].  
Another important feature of the analytes is the log P value; this should be in the range 1-4 
and in the case of higher lipophilicity (>4) the analytes could be trapped in the SLM and 
consequently challenging to back-extract into the aqueous acceptor solution [55, 64]. On the 
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other hand a log P value < 1 would impede the distribution from the sample solution and into 
the SLM; however this could be solved by addition of carrier molecules in the SLM [64]. 
1.4.6 Acceptor solution 
According to Eq. (2) an increase in the ion balance on the acceptor side to the sample side 
(low χ) is favourable to increase the flux over the SLM, and this was confirmed by 
experimental data [61]. The acceptor solution should preferably be directly compatible with 
LC-MS in order to circumvent the need for evaporation and reconstitution after extraction. 
1.4.7 Different EME configurations 
Electromembrane extraction was originally performed with the hollow fiber configuration 
presented in Fig. 1-5; however in recent years several alternative configurations have been 
developed. The drop-to-drop EME was investigated with flat polypropylene membranes as 
supporting material [80]; this setup is presented in Fig. 1-7.  
 
The sample solution was added to a sample well made by aluminium foil, a sheet of flat 
membrane was impregnated with an organic liquid and located in contact with the sample 
solution; thereafter 10 μL of acceptor solution was added on top of this SLM. This setup was 
totally stagnant and an electrical field in the range 3-20 V was applied. This approach 
provided selective isolation of pethidine, nortriptyline, methadone, haloperidol, and 
loperamide from pH adjusted water samples with extraction recoveries in the range 33-47% 
after 5 min of extraction [80].  
The drop-to-drop EME approach was relatively restricted in terms volume flexibility and thus 
limited the enrichment factor compared with the hollow fiber EME configuration. Another 
EME setup introduced in 2010 was the micro-chip configuration; this setup is presented in Fig. 
Fig. 1-7. Drop to drop EME. (Reprinted with permission from [58]. © 2011 Future Science Group) 
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1-8 [58, 83, 86]. In this setup the sample solution was infused with a flow rate in the range 1 
to 12 μL min-1 and upon contact with the SLM the analytes distributed into the SLM; 
subsequently the analytes migrated electrokinetically from the SLM and into the stagnant 
acceptor solution. The applied voltage was varied in the range 5-15 V and the extraction time 
was investigated up to 60 min; and the enrichment factor was reported to be proportional to 
the extraction time up to 60 min [83]. In another micro-chip EME approach also the acceptor 
solution was infused at a rate of 1-3 μL min-1 [86]; this setup reported extraction recoveries in 
the range 65-86% for pethidine, nortriptyline, methadone, haloperidol, loperamide, and 
amitriptyline. This paper demonstrated that micro-chip EME could be online coupled directly 
to the mass spectrometer for monitoring real time metabolism of amitriptyline by rat liver 
microsomes. Another EME approach was to use bags for housing the acceptor solution. This 
approach increased the acceptor volume which is considered as beneficial regarding 
extraction recovery [77, 79, 81].  
 
1.4.8 Extraction recovery, enrichment, and sample cleanup   
EME has been considered a non-exhaustive extraction technique; normally the analyte 
recoveries from aqueous samples are up to 80% [67]. Despite that EME is a non-exhaustive 
extraction technique, the combination of relatively high extraction recoveries with sensitive 
analytical instrumentation has provided sufficiently low lower limit of quantification (LLOQ) 
to quantitate concentrations in the lower ng mL-1 range. The extraction recoveries are highly 
dependent on the combination of organic liquid in the SLM, the applied voltage, and the 
extraction time [57-59] as discussed in previous sections.     
Fig. 1-8. Online EME. (Reprinted with permission from[58]. © 2011 Future Science Group) 
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The ratio between the sample and acceptor solution in addition to the extraction recovery 
determines the analyte enrichment. Typical acceptor solution volumes are in the range 10-30 
μL, and sample volumes in the range 100-500 μL. Enrichment factor up to 2198 has been 
reported [87]. The selective isolation of the analyte with EME and the exclusion of matrix 
components contribute to the efficient sample cleanup. The sample cleanup, often 
synonumous with absence of matrix components, should be investigated in the method 
validation protocol with the particular matrix, especially when HPLC is interfaced with 
electrospray ionization (ESI) in the mass spectrometer. Matrix effects occurs when matrix 
components retained on the analytical column co-elutes with the analytes; those interfering 
matrix components are often non-volatile and alters the droplet evaporation and subsequently 
affects the amount of charged ions eventually reaching the detector [88-90]. Consequently, a 
comprehensive sample preparation technique is often requested to circumvent the co-
extraction of such interfering matrix components.  
1.4.9 Calculation of extraction recovery (%) and enrichment 
The extraction recovery was calculated for each analyte according to Eq. (5): 
ܴ ൌ  ௡ೌǡ೑೔೙ೌ೗௡೏ǡ೔೙೔೟೔ೌ೗ ൈ ͳͲͲΨ ൌ ቀ
௩ೌ
௩೏ቁ ൬
௖ೌǡ೑೔೙ೌ೗
௖೏ǡ೔೙೔೟೔ೌ೗൰ ൈ ͳͲͲΨ      (5) 
where ݊ௗǡ௜௡௜௧௜௔௟ and ݊௔ǡ௙௜௡௔௟  are number of moles of the analyte in the the sample solution 
initially and in the final extract, respectively. ݒௗ and ݒ௔ are the volume of the sample- and 
acceptor solution, respectively.ܿௗǡ௜௡௜௧௜௔௟ and ܿ௔ǡ௙௜௡௔௟ are the concentration of the analyte in the 
sample- and acceptor solution, respectively. The enrichment factor (E) is calculated in 
accordance with Eq. (6).   
ܧ ൌ ൬ ௖ೌǡ೑೔೙ೌ೗௖೏ǡ೔೙೔೟೔ೌ೗൰          (6) 
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1.5 Dried blood spot (DBS) 
The idea of DBS sampling was introduced by Robert Guthrie already in 1963 [91], and this 
technique has obtained a widespread use in screening of phenylketonuria in newborns. 
Sampling by DBS was considered as a simplified sampling procedure compared to traditional 
sampling of blood samples from humans by venipuncture. Although the DBS approach was 
introduced already in 1963, the applications within the bioanalytical field have been limited. 
The limited use is mainly due to the fact that low sample volumes (10 μL) were insufficient to 
quantify endogenous drug concentrations with the contemporary analytical instrumentation. 
However, the interest for blood sampling of low sample volumes experienced a renaissance in 
the late 90s when the sensitivity of the analytical instrumentation was improved [92]. The 
DBS sampling procedure includes a heel- or finger prick; subsequently the capillary blood is 
applied to a solid material. Eventually, the blood spot is dried at room temperature for a 
certain time and stored in an air-tight container and transported to the laboratory. The storage 
of solid samples excludes the need for storage in a refrigerator or a freezer; dried biological 
samples are considered as non-hazardous and consequently simplify the transportation to the 
laboratory prior to analysis. Upon arrival at the laboratory a circular portion of the DBS is 
punched out and the analytes are eluted with a proper solvent prior to analysis by LC-MS [93-
95].  
The application of DBS has obtained a widespread use particularly in the preclinical phases in 
drug development in the pharmaceutical industry; the DBS approach has reduced the need for 
animals due to the reduction in sampling volume. DBS as sampling technique provides a 
number of advantages, like simple sampling procedures and low sample volumes, compared 
to blood collection by venipuncture [93, 96]. A wide range of sampling media is 
commercially available; however the clinical application of the DBS technique has been 
limited due to the concern of the blood spot diffusion in those media [94]. The blood spot 
diffusion is highly inter-individual and the area occupied with the same blood volume 
withdrawn from different subjects is inversely proportional to the blood viscosity [97]. The 
concern about the blood diffusion in the commercially available sampling materials has led to 
the investigation of alternative materials for DBS sampling. Nowadays, the interest for solid 
sampling of other biological matrices (e.g. urine, oral fluid, and plasma) has increased; the 
incorporation of other matrices into solid sampling introduced a new abbreviation into the 
bioanalytical field, Dried Matrix Spot (DMS).  
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1.6 High throughput sample preparation 
The interest for automation in the bioanalytical field increased in the 90s when faster LC-MS 
instrumentation became affordable for most routine laboratories. Consequently, the analysis 
time per sample was reduced and the sample preparation became the rate-limiting step of the 
total time consumption per sample [98]. High-throughput sample preparation was especially 
requested in the pharmaceutical industry to screen drug candidates. The introduction of multi-
well plates enabled sample preparation of multiple samples and is currently available in a 
wide range of dimensions and compartments. Multi-well plates could easily be operated by 
sophisticated liquid handling systems and the major sample preparation techniques (e.g. SPE, 
PP, supported liquid extraction (SLE), and filtration) have been incorporated into the multi-
well plate format and are now available in 96-, 384-, and 1536 well formats [12, 99, 100]. The 
combination of high-throughput sample preparation with fast analytical instrumentation 
provides an impressing sample throughput [98]. 
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2. AIM OF THE STUDY  
The overall aim of the present study was to further exploit electromembrane extraction (EME) 
as a sample preparation technique; and develop new technical configurations and applications 
in line with the recent trends reported in the bioanalytical field. The attention was particularly 
focused on sample volume, sample cleanup, contemporary sampling techniques, and high 
throughput sample preparation. A focus throughout the entire project was to reduce the 
number of steps in the EME procedures to an absolute minimum, and perform EME under 
physiological conditions to not disturb the fine-tuned endogenous equilibria. The questions 
we wanted to address in this thesis were as follows: 
 
Is it possible to use a battery to facilitate migration through a supported liquid membrane? 
Is it possible to isolate analytes with EME from post mortem blood? 
Is it possible to perform exhaustive EME from human plasma? 
Is it possible to combine EME with dried matrix spotting? 
Is it possible to increase the overall sample throughput with EME? 
Is the high-throughput EME platform robust? 
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3. RESULTS AND DISCUSSION 
The results reported in this section are presented in Paper I-VII; and only the key results are 
included in this context. 
3.1 Electromembrane extraction (EME) configurations 
A piece of polypropylene hollow fiber was utilized as supporting material and the lower end 
of the fiber was closed mechanically with a pincer. The supported liquid membrane (SLM) 
was made by impregnating the pores of the hollow fiber with an organic liquid for 5 s; the 
excess organic liquid was gently removed with a medical wipe. The acceptor solution was 
filled in the lumen of this hollow fiber with a microsyringe. The volume of the sample 
compartments were varied in the range 50-1000 μL. A pair of inert platinum wires was 
utilized as electrodes, the cathode and anode was placed in the acceptor- and the sample 
solution, respectively. The electrodes were connected to an adjustable power supply and the 
extraction compartment was placed on a shaking board (only for the compartments containing 
more than 300 μL of sample). This setup was used in Paper I, III, and V; a schematic 
drawing of the setup is presented in Fig. 3-1. 
 
In Paper II and IV the total number of hollow fibers was increased to three; this approach 
was selected in order to increase the surface area available for electrokinetic migration and 
thus improve the extraction recovery. In this configuration the acceptor solution was 
distributed into three separate hollow fibers, one cathode was placed in each of the three 
fibers as presented in Fig. 3-2. 
Fig. 3-1. The single fiber EME setup.   
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In Paper VI the hollow fiber configuration was replaced by a flat polypropylene membrane 
as supporting material. This configuration was made by sealing sheets of flat membranes to 
strips of plastic vials. Thereafter the lower end of the vials was cut and the polypropylene 
membrane was impregnated with an organic liquid; the excess organic liquid was gently 
removed with a medical wipe. Acceptor solution was filled into each of those wells. 
Aluminum foil coated with inert glue was attached to the walls of each well. A 96-well 
collection plate was used as sample reservoirs; each well in the 96-well collection plate was 
also coated with the above mentioned aluminum foil. The aluminum foils were connected 
with clips to an adjustable power supply, and the extraction compartment was placed on a 
shaking board. This setup provided a parallel coupled multi-well EME plate as presented in 
Fig. 3-3.  
 
 
 
Fig. 3-2. The three fiber EME setup. (Reprinted with permission from Paper II. © 2012 Elsevier)  
 
  
 
Hollow fibers + SLM housing 
acceptor solution 
Sample 
Anode 
Cathodes 
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In Paper VII the total number of parallel extractions in the parallel electromembrane 
extraction (Pa-EME) setup was increased to 96. The acceptor solution compartments were 
made with the same technique as described in Paper VI; however in Paper VII the strips 
were attached with glue to a pipette-tip rack to provide a 96-well plate. This approach 
demonstrated the throughput provided with a single power supply as driving force of the 96-
wells. A picture of the home-made 96-well Pa-EME configuration is presented in Fig. 3-4. 
 
 
 
 
 
 
 
Acceptor plate 
Aluminum foil (anode) 
Aluminum foil (cathode) 
Supported liquid 
membrane 
Sample plate 
Fig. 3-3. The Pa-EME setup with a schematic drawing of an extraction well. (Reprinted with 
permission from Paper VI. © 2014 Springer) 
Fig. 3-4. A picture of the 96-well Pa-EME setup.  
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3.2 EME of drugs 
The focus of this thesis was extraction of small molecular drug substances; their names, 
chemical stuctures, pKa values, and log P values are included in Table 3-1. 
Table 3-1. An overview over the model analytes, their chemical structure, pKa value, and log P. 
Analyte Structure pKa a log P a 
Amitriptyline 
 
9.18 4.41 
Amphetamine 
 
9.94 1.79 
Buprenorphine 9.47 2.83 
Cathinone 
 
7.97 0.92 
Citalopram 
 
9.57 3.48 
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2,5-dimethoxy-4-
iodoamphetamine 
(DOI) 
9.46 3.19 
Fluoxetine 
 
10.05 3.93 
Fluvoxamine 
 
9.39 3.71 
Haloperidol 
 
8.04 3.76 
Ketamine 
 
6.46 3.01 
Loperamide 
 
7.76 4.15 
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Methadone 
 
9.05 3.93 
3,4-Methylen 
dioxy-amphetamine 
(MDA)  
9.94 1.64 
3,4-Methylen 
dioxy-meth 
amphetamine 
(MDMA) 
 
10.32 2.05 
Methamphetamine 
 
10.38 2.20 
Nortriptyline 
 
10.0 3.97 
Paroxetine 9.68 3.70 
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Pethidine 
 
7.84 2.19 
Para-methoxy-
amphetamine 
(PMA)  
10.00 1.68 
Para-methoxy- 
methamphetamine 
(PMMA)  
10.53 1.86 
Quetiapine 
 
6.74 2.60 
Sertraline 
 
9.47 5.08 
a SciFinder (https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf, accessed 24.02.2014)  
3.2.1 Extraction time 
The major advantage of EME compared to other sample preparation techniques is the 
relatively short extraction time (1-10 min), and the fact that the analytes of interest are 
isolated and enriched into aqueous extracts directly compatible with analytical 
instrumentation in a single step. There is no need for evaporation to dryness and reconstitution 
in a proper solvent prior to analysis.  
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In Paper I a stagnant system was operated with a single 9 V battery as power supply. The 
extraction time in the evaluation protocol was set to 1 min. Despite the extraction time was 
only 1 min, the extraction recovery was adequate to quantify endogenous concentrations of 
the model substances. The extraction recoveries increased linearly from time zero up to 5 min 
and reached steady-state. A prolongation of the extraction time from 5 min did not increase 
the extraction recovery. Consequently, it is mandatory to have strict time control within the 
first 5 min of extraction because a slight increase in extraction time will significantly affect 
the extraction recovery. The extraction recovery (%) as function of extraction time is 
presented in Fig. 3-5. Extraction recoveries were in the range 12-22% for four basic drugs 
after 1 min of extraction; the extraction recoveries after 5 min were in the range 28-49%. 
 
 
In the theoretical considerations of EME it is suggested that the surface area is an important 
parameter regarding extraction recovery. Also convection is important to reduce the stagnant 
boundary layer and to promote electrokinetic migration from the sample solution and into the 
acceptor solution. In Paper II the surface area was investigated by increasing the number of 
hollow fibers in the sample from one to three. With this three fiber setup, exhaustive 
extractions were obtained of citalopram, loperamide, methadone, paroxetine, pethidine, and 
sertraline from samples of pH adjusted water within 10 min of extraction; however by 
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Fig. 3-5. Extraction recovery of fluoxetine (♦), amitriptyline (▪), citalopram (▲), and fluvoxamine (×) 
from untreated human plasma. (Reprinted with permission from Paper I. © 2010 Elsevier) 
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switching to spiked human plasma as sample matrix the extraction recoveries were reduced to 
some extent, especially for the highly protein bounded drugs (loperamide, paroxetine, and 
sertraline). 
In Paper IV the three fiber configuration investigated in Paper II was used to isolate the 
analytes of interest from 10 μL of whole blood spotted on a water soluble biopolymer. The 
punched out dried blood spot (DBS) was disintegrated in 1 mM HCl for 3 min and the 
analytes were subsequently isolated with the three-fiber EME setup within 10 min of 
extraction. This approach provided extraction recoveries similar to those reported in Paper II. 
The extraction recoveries obtained by combining water soluble bipolymers for DBS with 
EME were compared to commercially available sampling cards (Agilent Bond Elut DMS and 
Whatman FTA DMPK-A) and procedures for DBS analysis. Those experiments demonstrated 
that the combination of water soluble bipolymers with EME was superior to commercially 
available sampling cards both in terms of extraction recovery and time consumption per 
sample. However, the sample throughput with EME was inferior compared to both Agilent 
Bond Elut DMS and Whatman FTA DMPK-A, because until then only a single sample could 
be processed per time with EME. 
In Paper III the extraction time profile was investigated in the range 1 to 10 min with the 
optimized setup; the extraction recovery increased as function of the extraction time up to 5 
min as presented in Fig. 3-6 and reached steady-state. Consequently, the extraction was 
terminated after 5 min of extraction in the final setup. Although the extraction time was only 5 
min per sample, and considered as superior compared to conventional sample preparation 
techniques, a concern regarding the sample throughput with EME was emphasized by the 
collaborators at Norwegian Institute of Public Health (NIPH).  
 
Fig. 3-6. Extraction recovery (%) of cathinone (♦), methamphetamine (▪), MDA (▲), MDMA (×),
ketamine (×), and DOI (•) from untreated whole blood. (Reprinted with permission from Paper III. ©
2012 Elsevier) 
(%
) 
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Sampling of oral fluid as dried spots on alginate- and chitosan foam was combined with EME 
in Paper V; in this paper 10 μL of oral fluid spiked with model analytes was spotted on sheets 
of alginate- and chitosan foam. This spot of oral fluid was dried for three hours and 
subsequently disintegrated for 5 min in 1 mM HCl (pH 3) under strong agitation (3000 rpm), 
thereafter the analytes were isolated with EME from this solution and into 0.1% 
trifluoroacetic acid (TFA). The extraction time was optimized and 5 min of extraction was 
considered as the optimal extraction time and thus utilized in the evaluation protocol. 
Pa-EME with flat membranes was described for the first time in Paper VI. Due to the altered 
geometry with flat membranes compared to the hollow fiber EME setup, the extraction time 
was optimized with a Quality by Design (QbD) in the range of 1 to 10 min. The highest 
extraction recovery was obtained after 8 min and was in the range 15 to 33%. Consequently, 
the extraction time was set to 8 min in the evaluation protocol and provided simultaneous 
isolation of the analytes from eight human plasma samples into extracts compatible with 
liquid chromatography combined with mass spectrometry (LC-MS). In Paper VII the 
extraction times were varied in the range 5 to 10 min. The combination of  2-nitrophenyl octyl 
ether (NPOE) as SLM with extraction time of 10 min and extraction voltage of 300 V 
provided exhaustive extractions of amitriptyline, fluoxetine, and haloperidol. Paper VI and 
VII adressed the concern about sample throughput with the hollow fiber EME configuration 
and is considered as the initial step to in the future incorporate EME into the liquid handling 
platform.  
3.2.2 Supported liquid membrane 
The optimal organic liquid in EME should be low-viscous in order to effectively impregnate 
the supporting material and facilitate diffusion of the analytes of interest, non-volatile to 
prevent evaporation during the extraction process, and water-immiscible to prevent 
dissolution into the acceptor- and/or sample solution. The organic liquids and carrier 
molecules utilized in this thesis are presented in Table 3-2.    
In Paper I 1-ethyl-4-nitrobenzene (ENB), 1-isopropyl-4-nitrobenzene (IPNB), NPOE, and 2-
nitrophenyl pentyl ether (NPPE) were examined as SLM to isolate four hydrophobic drugs 
from human plasma samples; at extraction voltage below 20 V it was clear that ENB and 
NPPE were superior to NPOE. However, an increase in the extraction voltage provided 
extensive electrolysis due to a reduction in the SLM stability with both ENB and NPPE. This 
electrolysis resulted in a pH increase in the acceptor solution and consequently a reduction in 
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extraction recovery, also the RSD values increased. The observed RSD value increase was 
probably due to a substantial bubble formation and variations in the acceptor volume 
withdrawn after extraction. In the evaluation protocol ENB was selected as the SLM.  
In Paper II NPOE was selected as the SLM based on former experience [64] and the aim was 
to increase the extraction recovery of six hydrophobic drug substances with EME and the total 
number of hollow fibers was increased three-fold compared to conventional hollow fiber 
EME. Each of the three hollow-fibers was impregnated with NPOE and an extraction voltage 
of 200 V was applied and provided exhaustive extraction. The three fiber setup developed in 
Paper II with the same SLM was utilized in Paper IV to isolate four hydrophobic drugs from 
a disintegrated DBS.  
In Paper III six basic drugs of abuse were used as model analytes, the aim was to isolate 
those analytes from human whole blood. ENB, NPOE, NPPE, and 5% Di (2-etylhexyl) 
phosphate (DEHP) in NPOE (w/w) were investigated in order to select the most efficient 
SLM, and from those experiments ENB was selected as the organic liquid in the evaluation 
protocol. In Paper V EME was utilized to isolate buprenorphine, methadone, 
methamphetamine, PMA, and PMMA from samples of dried oral fluid disintegrated in 
hydrochloric acid. The SLM consisted of 10% tris (2-ethylhexyl) phosphate (TEHP) in IPNB 
(w/w); TEHP was added to the IPNB as a carrier molecule in order to increase the analytes 
affinity, particularly the more polar analytes (methamphetamine, PMA, and PMMA), for the 
SLM. 
The parallel EME configuration investigated in Paper VI was utilized to isolate amitriptyline, 
fluoxetine, quetiapine, and sertraline from human plasma samples. Based on former 
experience with the hollow fiber EME setup NPOE was selected as SLM [101, 102]. In Paper 
VII both NPOE and IPNB were utilized as organic liquids. NPOE was used in combination 
with high extraction voltage (up to 300 V) in an attempt to improve the extraction recovery. In 
the 68- and 96-well experiments IPNB was combined with low extraction voltage (20 V) due 
to safety considerations.   
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Table 3-2. Structure formulas of the organic solvents and carrier molecules in this thesis. 
Organic solvent  Structure 
1-Ethyl-4-nitrobenzene  
 
1-Isopropyl-4-nitrobenzene 
 
2-Nitrophenyl octyl ether 
 
2-Nitrophenyl pentyl ether 
 
Di (2-etylhexyl)phosphate 
 
Tris (2-ethylhexyl) phosphate 
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3.2.3 Extraction voltage 
Extraction voltage is another decisive parameter regarding extraction recovery in EME; 
however it is known that the stability of the SLM is highly dependent of the magnitude of the 
applied electrical field [66]. NPOE is considered as a stable SLM in EME, and the highest 
extraction recoveries are reported above 100 V with this particular organic liquid as SLM. In 
the case of IPNB and ENB the optimal extraction recoveries are reported with applied 
electrical fields below 25 V [63]. In EME there is a non-linear relationship between the 
magnitude of the applied electrical field and the extraction recovery for a given organic liquid 
sustained in the SLM. The stability of the organic liquid in the supporting material is 
mandatory in EME. If the applied voltage is increased up to certain point excessive 
electrolysis could occur. The more soluble the organic liquid is in the sample- or the acceptor 
solution the more electrolysis will occur. The electrolysis promotes excessive H2 gas 
formation in the acceptor solution, and consequently an increase in the pH-value [66].  
In Paper I ENB was selected as organic liquid. ENB provides decent extraction recoveries 
even at low extraction voltages. The extraction recoveries were investigated as function of the 
magnitude of the applied electrical field in the range 9 to 300 V, and the extraction recovery 
was considered as independent of extraction voltage in this setup. Since the idea of Paper I 
was to develop a simple and portable EME device, a 9 V battery was utilized as power supply 
in the final setup. The aim in Paper II was to isolate the analytes exhaustively from the 
sample solution and into the acceptor solution, in this setup three separate hollow fibers were 
located in the sample solution. NPOE was selected as SLM and the applied electrical field 
was investigated in the range 50 to 300 V. In the evaluation protocol 200 V was selected as 
the extraction voltage. 
In Paper III the extraction voltage was varied in the range 0 to 50 V with ENB as SLM; only 
a slight difference in extraction recovery was observed with 50 V compared to 5 V and 15 V. 
Consequently, a 15 V battery was selected as power supply in the final configuration. The 
three-fiber configuration presented in Paper II was utilized in Paper IV to isolate four basic 
drugs from a disintegrated dried blood spot sample, similar extraction recoveries were 
obtained from the DBS samples compared to human plasma as sample matrix. In Paper V the 
SLM consisted of 10% TEHP in IPNB (w/w) to increase the analytes affinity for the SLM; 
the extraction voltage was investigated in the range of 5 to 100 V and based on those 
experiments 25 V was selected as extraction voltage in the evaluation protocol.  
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In Paper VI the porous hollow fiber was replaced with a flat polypropylene membrane and 
this approach enabled operation of eight separate extraction compartments in parallel. The 
electrical circuits were connected to a single power supply and thus enabled the isolation of 
amitriptyline, fluoxetine, quetiapine, and sertraline from eight plasma samples simultaneously. 
The magnitude of the electrical field was optimized with a QbD in the range 20 to 200 V, and 
200 V was selected as the extraction voltage. The relationship between extraction recovery 
and extraction voltage was non-linear. In Paper VII the extraction voltage was varied from 
20 to 300 V depending on which organic liquid impregnated in the pores of the supporting 
material. 
3.2.4 Acceptor solution 
According to the modified Nernst-Planck equation the ionic strength of the acceptor solution 
would affect the extraction efficiency in the EME system. HCl has been utilized as acceptor 
solution in the majority of the research concerning EME. However, due to the non-volatility 
of HCl and incompatibility with LC-MS analysis, HCOOH was investigated as acceptor 
solution in Paper I. The replacement of HCl with HCOOH provided comparable extraction 
recoveries, and was utilized as acceptor solution in Paper I, II, IV, VI, and VII. In Paper III 
acetic acid, phosphoric acid, formic acid, and hydrochloric acid were investigated as acceptor 
solutions. Due to both MS compatibility and providing the highest extraction recoveries 10 
mM acetic acid was selected as the acceptor solution in the final setup. In Paper V 0.1% TFA 
was utilized as acceptor solution due to superior extraction recoveries compared to HCOOH. 
3.3 Evaluation parameters  
The final setup in Paper I-VI was evaluated regarding linearity, repeatability, extraction 
recovery, and sample cleanup as specified in regulatory guidelines [103, 104]. Satisfactory 
linearity and repeatability in the therapeutic range contributes to reliable detection and 
quantitation. The concentration range investigated was based upon either the therapeutic 
range (Paper I, II, IV, and VI) for the model substances, or concentrations associated with 
drug abuse (Paper III and V). Another important parameter to evaluate is the sample cleanup; 
any sample preparation technique should demonstrate its ability to selectively isolate the 
analytes of interest from the sample solution.  
3.3.1 Linearity 
The aim in Paper I was to develope a simple and stagnant EME-setup to isolate amitriptyline, 
citalopram, fluoxetine, and fluvoxamine from undiluted human plasma samples with relevant 
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therapeutic concentrations. The linearity of the aforementioned analytes was investigated in 
the range 1 to 1000 ng mL-1. This setup reported r2-values above 0.998 for all four analytes 
and was considered as satisfactory.  
The total number of hollow fibers in Paper II was increased to three in order to facilitate 
exhaustive EME, and the linearity regarding citalopram, loperamide, methadone, paroxetine, 
pethidine, and sertraline was investigated in the range 1 to 1000 ng mL-1. This particular setup 
reported r2-values above 0.990 regarding all six model analytes and was considered as 
acceptable.  
The concentration range selected in Paper III to evaluate the linearity was 10 to 250 ng mL-1 
and this was based on concentrations typically associated with drug abuse of cathinone, 
methamphetamine, MDA, MDMA, ketamine, and DOI [105]. This EME approach combined 
with UPLC-MS/MS reported r2-values above 0.9939 for the selected drugs of abuse. 
In Paper IV the linearity was examined in the range 17.5 to 560 ng mL-1, and the r2-values 
reported were 0.983, 0.986, 0.992, and 0.9952 for citalopram, loperamide, methadone, and 
sertraline, respectively. Although the r2-value for citalopram and loperamide was below 0.990 
it was considered as satisfactory due to the homebuilt equipment and the fact that only 10 μL 
of whole blood, which is highly challenging to pipette accurately, was spotted on the sheets of 
foam.  
In Paper V the linearity was investigated in the range 25 to 1000 ng mL-1 for five basic drugs 
of abuse and the reported r2-values were above 0.991 for all analytes except from 
buprenorphine. The r2-value obtained by combining oral fluid spiked with buprenorphine and 
sampling on chitosan foam was 0.989; nevertheless this was considered as acceptable. 
In the Pa-EME approach investigated in Paper VI, the linearity for amitriptyline, fluoxetine, 
quetiapine, and sertraline was examined in the range 1 to 400 ng mL-1, and reported r2-values 
above 0.9974 and considered as acceptable. Paper VII was an extension of the setup 
developed in Paper VI and the linearity was therefore not investigated with this particular 
configuration.    
3.3.2 Repeatability 
The repeatability is considered as an important evaluation parameter in the field of bioanalysis, 
and guidelines often requests RSD-values below 20 and 15% for low- and high concentration, 
respectively [103, 104]. In this study the repeatability has been utilized as one of the 
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parameters to rate the success of the investigated EME configurations. Although the EME 
configurations were homebuilt, an acceptable repeatability was reported throughout this study. 
In Paper I the RSD-values were in the range 3.2-8.9% at 100 ng mL-1. In Paper II the RSD-
values were below 22% and 21% at 10- and 1000 ng mL-1, respectively, for the six basic 
model substances. In Paper III the RSD-values were below 27% and 26% at 10- and 50 ng 
mL-1, respectively. In Paper IV the RSD-values were below 20% at 17.5-, 140-, and 1120 ng 
mL-1. In Paper V the RSD-values were below 15% at 50 ng mL-1. In Paper VI the RSD-
values were below 15% at 2-, 10-, and 200 ng mL-1. In Paper VII the RSD-values were 
below 15%, the 96-well experiment reported RSD values of 4-, 4-, and 6% for amitriptyline, 
fluoxetine, and haloperidol, respectively. Those small RSD values were probably due to the 
number of parallels (96) in this experiment.  
3.3.3 Extraction recovery 
The extraction recovery has been investigated in each setup and utilized to grade the success 
of the extraction process. The extraction recovery is highly dependent on the extraction time, 
the organic liquid sustained in the pores of the supporting material, the applied voltage, the 
acceptor solution volume, and the rate of agitation (especially with larger compartments).  
A stagnant configuration was utilized in Paper I to isolate amitriptyline, citalopram, 
fluoxetine, and fluvoxamine from 70 μL of untreated human plasma; and the extraction 
recovery was in the range of 28-49% at the steady-state level. Another approach was 
investigated in Paper II; the total number of hollow fibers introduced into the sample was 
three and this increased the acceptor solution volume and the total surface area available for 
electrokinetic migration. According to the modified Nernst-Planck equation this should 
increase the extraction recovery. The extraction recoveries of citalopram, loperamide, 
methadone, paroxetine, pethidine, and sertraline were in the range 97-115% from pH adjusted 
water samples; however from undiluted human plasma the extraction recoveries were in the 
range 56-102%. This reduction in extraction recovery observed from human plasma, was 
probably due to proteinbinding of the analytes.  
In Paper III the six stimulating drugs cathinone, methamphetamine, MDA, MDMA, 
ketamine, and DOI were isolated from samples of undiluted whole blood. The extraction 
recoveries after 5 min were in the range 9-28%. In Paper IV the setup from Paper II was 
combined with DBS sampling on sheets of alginate foam with citalopram, loperamide, 
methadone, and sertraline as model substances. After disintegration of the punched out DBS, 
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the analytes were isolated with EME and provided extraction recoveries in the range 44-105%. 
Those recoveries were comparable to the results reported in Paper II. In Paper V sheets of 
alginate- and chitosan foam were utilized as sampling media for oral fluid spiked with 
buprenorphine, methadone, methamphetamine, PMA, and PMMA. The punched out dried 
oral fluid was disintegrated instantly with 1 mM HCl and the analytes were isolated from this 
solution and into the acceptor solution prior to analysis. The extraction recoveries with EME 
were 25-65% and 28-64% for sampling on alginate- and chitosan foam, respectively.  
In Paper VI the hollow fiber was replaced by a flat membrane, and thus altered the geometry 
of the extraction unit. The volume of the reservoirs housing acceptor solution was increased 
and this provided an increased flexibility in terms of acceptor solution volume compared to 
hollow fiber EME. The Pa-EME configuration provided extraction recoveries in the range 16 
to 31% from samples of undiluted human plasma (at 10 ng mL-1) after 8 min of extraction.  
In Paper VII the magnitude of the applied electrical field and extraction time was 250 V and 
10 min, respectively, and this configuration provided exhaustive extraction of amitriptyline, 
fluoxetine, and haloperidol from pH adjusted water samples. In addition, this setup was 
utilized to isolate the aforementioned analytes from undiluted human plasma and reported 
extraction recoveries in the range 79-101%.  
3.3.4 Sample cleanup 
Another considerable advantage with EME is the sample cleanup and the compatibility of the 
extracts with analytical instrumentation without the need for evaporation and reconstitution. 
The sample cleanup provided with EME is mainly due to the selective character of the SLM. 
The sample cleanup has been investigated both with blank extractions and post-column 
infusion experiments throughout this study.  
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In Paper I EME was compared with solid phase extraction (SPE) and protein precipitation 
(PP) in terms of co-extracted matrix components from human plasma in the final extract. The 
sample cleanup provided with EME was comparable with the sample cleanup obtained with 
the SPE procedure; PP provided a massive peak which comprised matrix components as 
presented in Fig. 3-7 with capillary electrophoresis with ultraviolet detection (CE-UV).  
 
In Paper IV the sample cleanup was examined with a post-column infusion LC-MS 
experiment in order to detect potential matrix components in the final extract. The sample 
matrix was highly complex and consisted of whole blood, foam constituents, and the four 
basic analytes; nevertheless neither an increase nor decrease in the signal intensity in the MS 
was observed after injection of a blank extract. This underlined the excellent sample cleanup 
provided with EME from complex matrices. The same setup was utilized in Paper V; 
however in this case the sample matrix was oral fluid. Traditionally sampling of oral fluid is 
conducted with a sampling pad in the oral cavity; subsequently the pad is stored in a buffer 
prior to analysis by LC-MS. This buffer has been reported to provide extensive matrix effects 
in the MS and inaccurate quantitation [106]. In Paper V the sampling of oral fluid was 
conducted on a solid material and the need for a storage buffer was omitted. The post-column 
infusion experiments in Paper V demonstrated the excellent sample cleanup obtained with 
Fig. 3-7. CE-UV examination of sample cleanup provided with EME, PP, and SPE, respectively. 
(Reprinted with permission from Paper I. © 2010 Elsevier)  
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EME; in another experiment a blank extract was analyzed to examine any matrix constituents 
in the final extract. No additional peaks in the chromatogram were detected in this experiment.  
In Paper VI the sample cleanup from human plasma was investigated with a post-column 
infusion LC-MS experiment presented in Fig. 3-8; also the flat membrane configuration 
provided excellent sample cleanup and no matrix components were detected in the final 
extract. The absence of matrix components from plasma, whole blood, and oral fluid in the 
EME extracts emphasized the sample cleanup provided with EME.  
 
 
3.4 Real samples 
3.4 Real samples 
A sample preparation technique should be easy to implement in routine laboratories, be user 
friendly, and contribute to accurate detection and quantitation in the final analysis. In this 
section the applicability of the different EME approaches are discussed based on experiences 
with real samples. The results from the 15 different subjects are summarized in Table 3-3.  
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Fig. 3-8. LC-MS/MS chromatogram after injection of a 50 ng mL-1solution of amitriptyline, fluoxetine, 
fluoxetine d5, quetiapine, and sertraline (a). Post-column infusion LC-MS/MS chromatogram (b).
(Reprinted with permission from Paper VI. © 2014 Springer) 
a) b) 
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Table 3-3. Overview over the endogenous concentrations reported with EME on real samples and the 
deviation (%) from the concentrations reported by a reference laboratory, paper no. in parentheses.  
Subject # Drug EME-LC/MS Deviation 
Subject 1 (I) Citalopram 42 ng mL-1 -17% 
Subject 2 (I) Citalopram 67 ng mL-1 -23% 
Subject 3 (II) Citalopram 46 ng mL-1 -4% 
Subject 4 (II) Citalopram 86.5 ng mL-1 - 
Subject 5 (II) Citalopram 58 ng mL-1 14% 
Subject 6 (III) Cathinone 2.9 ng mL-1 n.m 
Subject 7 (III) Cathinone 1.3 ng mL-1 n.m 
Subject 8 (III) Amphetamine 138 ng mL-1 28% 
 Methamphetamine 558 ng mL-1 34% 
Subject 9 (III) Amphetamine 90 ng mL-1 32% 
 Methamphetamine 226 ng mL-1 26% 
 Ketamine 379 ng mL-1 -6% 
Subject 10 (III) Amphetamine 386 ng mL-1 -14% 
 Methamphetamine 996 ng mL-1 -13% 
 MDMA 405 ng mL-1 -25% 
 MDA 21 ng mL-1 n.m 
Subject 11 (III) Ketamine 1952 ng mL-1 24% 
Subject 12 (III) MDMA 3005 ng mL-1 4% 
 MDA 80 ng mL-1 n.m 
Subject 13 (III) Amphetamine 141 ng mL-1 16% 
 Methamphetamine 316 ng mL-1 25% 
Subject 14 (VI) Quetiapine 56 ng mL-1 -30% 
Subject 15 (VI) Sertraline 6 ng mL-1 - 
n.m = not measured by the reference laboratory 
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In Paper I plasma samples from three subjects treated with the antidepressant drug citalopram 
were obtained (subject 1-3 in Table 3-3); 70 μL untreated plasma from those subjects were 
added to the sample vial. Subsequently, the hollow fiber was impregnated with ENB and 30 
μL 10 mM formic acid was filled in the lumen of this hollow fiber. Citalopram was isolated 
from each sample (n=3) under an applied electrical field of 9 V within 1 min of extraction, 
and the final extract was analyzed by LC-MS. A chromatogram from one of the subjects is 
presented in Fig. 3-9. The calibration curve was utilized to determine the plasma 
concentration in the patient samples; the plasma concentrations found were 42-, 67-, and 46 
ng mL-1 and deviated less than 23% compared to the plasma concentration reported by a 
reference laboratory. 
 
 
Also in Paper II the final EME setup was utilized to isolate citalopram from two subjects 
(subject 4 and 5 in Table 3-3); in this setup 50 μL undiluted plasma was filled in the sample 
compartments and each of the three hollow fibers were impregnated with NPOE and filled 
with 7 μL formic acid (21 μL in total). Citalopram was isolated from the samples and into the 
acceptor solution within 10 min and with 200 V as the magnitude of the applied electrical 
field. The final extract was analyzed by LC-MS. The plasma concentration reported with 
EME-LC-MS of subject 4 and 5 was 86.5 and 58 ng mL-1, respectively; those results deviated 
less than 14% compared to the plasma concentration reported by a reference laboratory. 
The sample matrix in Paper III was whole blood; and EME was utilized to isolate different 
stimulating drugs from whole blood samples (subject 6-13 in Table 3-3). The optimized setup 
was utilized to isolate the analytes of interest from five forensic samples from living persons 
Fig. 3-9. EME combined with LC-MS for determination of citalopram in a real sample. (Reprinted with
permission from Paper I. © 2010 Elsevier) 
PhD thesis Lars Erik Eng Eibak  3. RESULTS AND DISCUSSION 
47 
 
and three forensic autopsy cases. A chromatogram of subject 6 is included in Fig. 3-10. Post-
mortem blood from autopsy cases is considered a more complex matrix compared to whole 
blood; mainly due to the hemolysis of blood cells and increased viscosity. In this setup 80 μL 
whole blood was filled in the sample vial, the hollow fiber was impregnated with ENB, and 
subsequently filled with acetic acid; the analytes were isolated from the sample and into the 
acceptor solution within 5 min of extraction and 15 V as extraction voltage. The final extract 
was analyzed by UPLC-MS/MS. The results obtained with EME combined with UPLC-
MS/MS provided a deviation in the range -13 to 34% compared to the results reported by 
NIPH.  
 
 
In Paper VI plasma samples from two subjects (subject 14 and 15 in Table 3-3) treated with 
quetiapine and sertraline, respectively, were obtained. The analytes of interest were isolated 
from 240 μL of plasma sample, across a supported liquid membrane consisting of NPOE, and 
into 70 μL formic acid. The extraction time was 8 min, the applied voltage was 200 V, and 
the extraction compartment was subjected to 900 rpm throughout extraction. The final extract 
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Fig. 3-10. EME combined with UPLC-MS/MS for determination of cathinone in an authentic sample, 
MDMA d5 was utilized as internal standard. (Reprinted with permission from Paper III. © 2012
Elsevier) 
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was analyzed by LC-MS/MS. The reported plasma concentration was 56- and 6 ng mL-1 for 
quetiapine and sertraline, respectively. The chromatograms of subject 14 and 15 are presented 
in Fig. 3-11. In Paper VI three parallels from each subject was processed simultaneously. 
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Fig. 3-11. EME combined with LC-MS/MS for determination of quetiapine (a) and sertraline (b), 
respectively. Fluoxetine d5 was utilized as internal standard. (Reprinted with permission from Paper 
VI. © 2014 Springer) 
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The concentration reported with EME in combination with LC-MS, LC-MS/MS or UPLC-
MS/MS deviated ± 30% compared to the drug concentration stated by the reference 
laboratories. Taken into consideration that some of the samples have been stored over a year 
under unknown conditions this deviation is considered as acceptable and demonstrated the 
applicability of EME on real samples.  
3.5 EME in combination with dried matrix spot (DMS) 
The interest for solid sampling of microliter volumes of biological fluids has increased the last 
five years; mainly due the increased sensitivity provided by state-of-the-art analytical 
instrumentation [94, 95, 107-110]. However, the robustness of the current sampling materials 
for DMS analysis has been extensively debated the last years. The discussions are mainly 
focused on the homogenity of the applied blood spot and the influence of hematocrit on the 
blood spot diffusion [111-113]. The introduction of sampling media with pH-dependent 
solubility demonstrated at totally new approach to address the concern about blood diffusion 
in a solid material. The selected media exerted high absorbing capacity and were stable under 
physiological conditions (pH 7), however upon hydration at pH 3 it fully disintegrated within 
5 min. After disintergration, the analytes were isolated with EME into aqueous extracts 
directly compatible with analytical instrumentation.   
3.5.1 Human whole blood 
In Paper IV EME was combined with solid sampling on a novel DMS medium addressing 
the challenges reported with the commercially available materials. Two different media were 
provided as sheets of foam by the Department of Pharmaceutics at School of Pharmacy 
(University of Oslo). The first one consisted of alginate which is a linear copolymer with 
homopolymeric blocks of (1Ѹ4)-linked β-D-mannuronate and the C-5 epimer α-L-guluronate. 
Chitosan was the second medium and this is a cationic copolymer of glucosamine units. 
Those media should be stable at physiological pH, and disintegrate instantly under acidic 
conditions. Both media provides high absorbing capacity [114-116].  
 
Human whole blood spiked with citalopram, loperamide, methadone, and sertraline was 
spotted on the either alginate- or chitosan foam and dried for 3 hours at room temperature; 
thereafter the entire DBS spot was punched out and disintegrated in 1 mM HCl for 3 min. A 
picture of the DBS and the solution obtained after disintegration for 3 min is presented in Fig. 
3-12. The analytes were isolated from this solution (Fig. 3-12b) and into 21 μL formic acid 
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within 10 min of EME with the three-fiber configuration introduced in Paper II. The final 
extract was analyzed by LC-MS. The extraction recovery with this setup for the four basic 
analytes was in the range 44-105% and 57-115% for alginate- and chitosan foam, respectively, 
and comparable to the extraction recoveries reported for the same analytes in Paper II from 
untreated human plasma.  
  
 
 
 
 
Sampling on alginate- and chitosan foam in combination with EME was compared with 
sampling on Agilent Bond Elut DMS and Whatman FTA DMPK-A in combination with 
standard elution procedures (typically acidified acetonitrile or methanol). The different 
procedures were evaluated regarding recovery and time consumption. Agilent Bond Elut 
DMS provided elution recovery from the punched out DBS in the range of 59 to 69% within 
60 min of elution, and Whatman FTA DMPK-A provided recoveries in the range of 11 to 33% 
within 10 minutes of elution. Additionally, the solution obtained with Agilent Bond Elut 
DMS and Whatman FTA DMPK-A after elution has to either be evaporated to dryness and 
reconstituted or centrifuged prior to final analysis. This post-elution step prolong the sample 
preparation time. With sampling on either alginate- or chitosan foam the sample preparation 
time is 15 min to provide extracts directly injectable in LC-MS.     
Fig. 3-12. Pictures of 10 μL whole blood spotted on sheets of alginate foam (a) and the solution 
obtained after disintegration of the punched out blood spot for 3 min in 1 mM HCl (b), respectively. 
(Reprinted with permission from Paper IV. © 2012 American Chemical Society)  
            a)                                                          b) 
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3.5.2 Human oral fluid 
In Paper V sheets of alginate- and chitosan foam were used for sampling of oral fluid. 10 μL 
oral fluid spiked with buprenorphine, methadone, methamphetamine, PMA, and PMMA was 
spotted on sheets of alginate- and chitosan foam as presented in Fig. 3-13. A fixed circular 
portion, which included the entire spot, was punched out and disintegrated in 300 μL 1 mM 
HCl for 5 min, the five analytes were subsequently isolated with EME into 25 μL 0.1% TFA 
in 5 min, and analyzed by LC-MS. The selective isolation of the analytes from the complex 
solution consisting of oral fluid, foam constituents, and hydrochloric acid was provided within 
10 min. The reason for sampling oral fluid on solid materials was to investigate an alternative 
to oral fluid sampling with a sampling pad in the oral cavity which has been reported to 
provide extensive matrix effects as discussed in section 3.3.4.  
 
In Paper IV and V EME was successfully combined with DMS sampling. A novel DMS 
concept was introduced as an attempt to address the challenges reported in the literature 
concerning the commercial DMS media. The novel media in combination with EME as 
sample preparation technique provided a powerful tool both for sampling and subsequent 
isolation of the analyte prior to LC-MS analysis. 
3.6 High throughput EME 
The idea of parallel extractions with EME was briefly investigated in Paper I by coupling 
three separate electrical circuits in parallel to a single 9 V battery. This setup isolated 
amitriptyline, citalopram, fluoxetine, and fluvoxamine from 70 μL human plasma into 30 μL 
formic acid in 60 seconds of extraction. The extraction recoveries were found to be unaffected 
by the total number of samples processed at the same time. The hollow fiber configuration 
presented in Fig. 3-14 was challenging to operate, and the idea of Pa-EME re-emerged after 
the introduction of parallel artificial liquid membrane extraction (PALME) in 2013 [40].  
Fig. 3-13. Picture of 10 μL oral fluid spotted on sheet of alginate foam (a) and chitosan foam (b). 
(Reprinted with permission from Paper V. © 2013 Future Science Group) 
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In Paper VI the Pa-EME configuration with flat membranes was described for the first time. 
In this setup flat polypropylene membranes were attached with heat to strips of plastic vials. 
The lower end of those vials were cut of and served as a multi-well plate. A 96-well plate 
served as sample reservoirs. Sheets of aluminum foil were attached in fixed positions to both 
the multi-well plate and the sample reservoirs; thus creating an electrical circuit across each of 
the 96 wells. The four basic drugs amitriptyline, fluoxetine, quetiapine, and sertraline were 
selected as model substances. NPOE was selected as the SLM based upon experiences with 
the hollow fiber electromembrane extractions (HF-EME) configuration [101, 102]; undiluted 
human plasma was the sample matrix and 20 mM formic acid was choosen as acceptor 
solution due to its LC-MS-compatibility. Since Pa-EME with flat membranes was 
investigated for the first time: extraction time, extraction voltage, agitation speed, sample 
solution volume, and acceptor solution volume were optimized with QbD. The final Pa-EME 
configuration provided isolation of amitriptyline, fluoxetine, quetiapine, and sertraline from 
eight plasma samples into LC-MS compatible extracts simultaneously by utilizing a single 
power supply.  
The sample throughput with the Pa-EME configuration was increased in Paper VII, 68- and 
96 samples were processed in parallel with the configuration presented in Fig. 3-4. The 
extraction recoveries were unaffected by the total number of samples processed in parallel 
with the 96 well Pa-EME configuration, the results are presented in Fig. 3-15.  
Fig. 3-14. Pa-EME with the hollow fiber configuration. (Reprinted with permission from Paper I. © 
2010 Elsevier) 
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Also the volume of the acceptor solution compartments were increased in Paper VII and thus 
provided an opportunity to alternate the acceptor solution volume compared to the HF-EME 
configurations. Typical acceptor solution volume with the hollow fiber setups have been in 
the range 10-30 μL, in Paper VII the volume of acceptor solution was 100-150 μL. High 
acceptor solution volume in EME has been considered as favourable to increase the extraction 
recovery and exhaustive extraction was reported from pH adjusted water samples in Paper 
VII.   
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Fig. 3-15. Extraction recovery (%) with the Pa-EME configuration of amitriptyline, fluoxetine, and 
haloperidol, respectively.  
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CONCLUDING REMARKS 
In this thesis the potential of selective isolation with electromembrane extraction (EME) of 
ionized analytes from biological matrices has been investigated. Major focus was on 
extraction of small molecular drug substances from human matrices; extraction at low 
voltages (<10 V), short extraction times (<10 min), exhaustive extraction, and parallel 
extractions of multiple samples. EME was also combined with dried matrix spotting on sheets 
of soluble alginate- and chitosan foams. 
x The development of a portable and stagnant electromembrane extraction device with a 
single 9 V battery as the only driving force provided selective isolation in the 
therapeutic range of four basic drugs within 1 min of extraction. This approach also 
reported interesting findings concerning the potential of parallel extractions with a 
single power supply as driving force. 
  
x Exhaustive extractions from undiluted human plasma were reported by increasing the 
total number of hollow fibers in the sample solution from one to three and thus 
increase the surface area available for electrokinetic migration.  
 
x The selective isolation of ionized analytes provided with EME was demonstrated from 
both whole- and post-mortem blood. This approach demonstrated the potential of 
EME in forensic science. 
 
x Electromembrane extraction was combined with sampling on a novel sampling 
material for dried blood spot analysis. The combination of EME with sampling on 
water soluble biopolymers reported a substantial reduction in time consumption 
compared to commercially available sampling media.  
 
x Sampling of oral fluid on sheets of water soluble biopolymers was combined with 
electromembrane extraction for isolation and enrichment of five basic drugs of abuse. 
This approach reported findings regarding sampling of oral fluid as dried spots on 
water soluble biopolymers and selective isolation of the drugs with EME. 
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x The sample throughput with EME was increased with the multi-well flat membrane 
format and demonstrated the potential for incorporation of electromembrane extraction 
into the liquid handling platform in the future. 
 
x The sample throughput was increased with the 96-well format, and was considered as 
unaffected by small, but deliberate variations in method parameters in a normal 
laboratory setting. 
In order to be established as a sample preparation technique of significance in the future the 
homemade configurations has to be omitted and electromembrane extraction has to be 
commercialized. Hopefully, this will increase the interest from academic as well as routine 
laboratories worldwide, the theoretical understanding and fundament should be even more 
thoroughly investigated in order to solve challenges which are not possible with existing 
sample preparation techniques.  
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Abstract 42 
The robustness of parallel electromembrane extraction (Pa-EME) was thoroughly investigated 43 
in the present project. Amitriptyline, fluoxetine, and haloperidol were isolated from eight 44 
samples of pure water, undiluted human plasma, and undiluted human urine, respectively; 45 
totally 24 samples were processed in parallel. The extraction performance, expressed as 46 
extraction recovery and repeatability, was found to be independent of the different sample 47 
matrices processed in parallel although the respective samples contained different matrix 48 
components. In another experiment seven of the 24 wells were perforated. Even though the 49 
perforation caused the total current level in the Pa-EME setup to increase, the intact circuits 50 
were unaffected by the collapse in seven of the circuits. In another approach, exhaustive 51 
extraction of amitriptyline, fluoxetine, and haloperidol was demonstrated from pure water 52 
samples. Amitriptyline and haloperidol were also isolated exhaustively from undiluted human 53 
plasma samples; the extraction recovery of fluoxetine from undiluted human plasma was 81%. 54 
Finally, the sample throughput was increased with the Pa-EME configuration. The extraction 55 
recoveries were investigated by processing one, eight, 68, or 96 samples in parallel in 10 min; 56 
neither the extraction recoveries nor the repeatability was affected by the total numbers of 57 
samples. Eventually, the Pa-EME was combined with ultra performance liquid 58 
chromatography (UPLC) to combine high-throughput sample preparation with high-59 
throughput analytical instrumentation.    60 
 61 
 62 
 63 
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Introduction 64 
The interest for less solvent consumption and miniaturized sample preparation techniques 65 
have increased recently due to faster and more sensitive analytical instrumentation. The 66 
sample volume has been reduced substantially, typically from 1-5 mL to 10-50 μL, with 67 
miniaturized extraction techniques in comparison with more traditional sample preparation 68 
techniques like liquid-liquid extraction (LLE), solid-phase extraction (SPE), filtration, and 69 
protein precipitation (PP). Electromembrane extraction (EME) was described for the first time 70 
in 2006 and demonstrated electrokinetic migration of charged substances from an aqueous 71 
sample solution through a supported liquid membrane (SLM) and into an aqueous acceptor 72 
solution [1]. The driving force in EME is an applied electrical field. The acceptor solution is 73 
directly compatible with final analysis for instance by, but not limited to, LC-MS without the 74 
need for evaporation to dryness and reconstitution in an appropriate solvent.  75 
Since the introduction of EME in 2006 several papers have described the fundamentals of 76 
electrokinetic migration of charged analytes through an SLM [2-5]. EME is considered as a 77 
robust, fast, and environmental-friendly sample preparation technique due to the acceptable 78 
RSD-values (<20%), the short extraction time (1-10 min), and the low consumption of 79 
organic liquid (<10 μL); several review articles have been published the recent years [6, 7]. 80 
The SLM provides a barrier which excludes sample constituents from entering the acceptor 81 
solution; and provides extracts free of interfering matrix constituents [8-10]. Applications 82 
based on EME have been utilized to isolate basic drugs [11, 12], acidic drugs [13], peptides 83 
[14], analytes from dried matrix spotting [8, 10, 15], amino acids [16, 17], and lead ions [18] 84 
from different types of sample matrices. Although numerous benefits have been reported with 85 
EME, the sample throughput has been limited and considered as a drawback compared to 86 
other extraction techniques which have been incorporated into the high-throughput platforms. 87 
High sample throughput is especially requested by the pharmaceutical industry as a tool in the 88 
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search for novel drug candidates. The incorporation of sample preparation techniques into 89 
multi-well plates and parallel extractions has been considered as an important advance in the 90 
field of sample preparation [19].  91 
The idea of parallel electromembrane extraction (Pa-EME) was briefly investigated in 2010 92 
with the hollow fiber configuration; in this setup three extraction units were connected in 93 
parallel to a single 9 V battery [20]. The Pa-EME configuration enabled the isolation of 94 
amitriptyline, citalopram, fluoxetine, and fluvoxamine into formic acid from three different 95 
plasma samples simultaneously with RSD-values in the range 7.8 to 18.1% [20]. The Pa-EME 96 
with the hollow fiber configuration was challenging to operate; however the introduction of 97 
flat membranes [21] simplified the processing of multiple samples with Pa-EME substantially. 98 
Very recently the idea of Pa-EME with the flat membrane configuration was introduced [9]; 99 
in this setup amitriptyline, fluoxetine, quetiapine, and sertraline was isolated into formic acid. 100 
Eight plasma samples were processed simultaneously in separate wells within eight minutes 101 
of extraction with RSD-values in the range 5-15% [9]. This setup reported extraction 102 
recoveries in the range 15 to 33% from undiluted human plasma spiked with the 103 
abovementioned model analytes. Although the extraction recoveries were relatively low, the 104 
combination of Pa-EME with sensitive LC-MS/MS instrumentation provided limit of 105 
quantification (LOQ) below the therapeutic levels. Eventually, the Pa-EME setup in 106 
combination with LC-MS analysis was successfully utilized to determine the plasma 107 
concentration from patients treated with quetiapine and sertraline. This was considered as the 108 
first attempt to incorporate EME with flat membranes into the multi-well format [9]. 109 
In the present investigation the Pa-EME setup was exploited more thoroughly. Different 110 
biological matrices were processed in parallel to investigate if the Pa-EME setup remains 111 
unaffected by small, but deliberate variations in method parameters and is reliable during 112 
normal use. In addition, several of the wells in the Pa-EME setup were perforated during 113 
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extraction in order to investigate the impact of this interruption on the remaining wells. Also 114 
the total number of samples processed simultaneously was increased from eight to 68 and 115 
finally to 96. The magnitude of the applied electrical field, the acceptor solution volume, and 116 
the extraction time were optimized in order to accomplish exhaustive EME from undiluted 117 
human plasma. 118 
 119 
 120 
 121 
 122 
 123 
 124 
 125 
 126 
 127 
 128 
 129 
 130 
 131 
 132 
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Experimental  133 
Chemicals 134 
Amitriptyline hydrochloride, fluoxetine hydrochloride, and haloperidol were all obtained from 135 
Sigma-Aldrich (St.Louis, MO, USA). Formic acid and 2-nitrophenyl octyl ether were 136 
obtained from Fluka (Buchs, Switzerland). Drug free human plasma was obtained from Oslo 137 
University Hospital (Oslo, Norway) and stored at -32 °C. Drug-free human urine was 138 
obtained from a healthy volunteer. Water was obtained from a Milli-Q water purification 139 
system (Molsheim, France).  140 
Preparation of the parallel electromembrane extraction setup 141 
The Pa-EME setup was homemade by heat-sealing of circular sheets of a porous 142 
polypropylene flat membrane Accurel PP 1E (R/P) from Membrana (Wuppertal, Germany) 143 
with 244 °C for 5 sec with a heather from CoTech (Innsjon, Sweden) to nABgene 0.2 mL 144 
strip tubes from Thermo Scientific (Loughborough, UK). Subsequently, the lower part of the 145 
plastic vials were cut off and attached with glue to a pipette tip rack. A 96-well collection 146 
plate from Agilent (Santa Clara, CA, USA) was utilized as the donor solution compartment. 147 
Both the multi-well plate and the donor compartments were coated with Platemax™ 148 
aluminum foil (Union City, CA, USA) in a fixed position to serve as electrodes in the Pa-149 
EME setup. The 96-well Pa-EME setup is presented in Fig.1. The aluminium foils were 150 
connected with clips to an adjustable power supply from Delta Power Supplies (Zierikzee, the 151 
Netherlands). The extraction compartment was placed on a Vibramax 100 from Heidolph 152 
Instruments (Kelheim, Germany) and subjected to a given agitation rate throughout the 153 
extraction. 154 
Capillary electrophoresis   155 
The final analysis was performed by capillary electrophoresis in combination with UV-156 
detection with an HP3D CE instrument from Agilent Technologies (Waldbronn, Germany). 157 
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The three basic drug substances were separated in a 50 cm effective length fused silica 158 
capillary with an internal diameter of 75 μm from Polymicro Technologies (Phoenix, AZ, 159 
USA). The electrolyte solution was a 25 mM phosphate buffer adjusted to pH 2.7 with 25 mM 160 
orto-phosphoric acid. The final extract was injected by hydrodynamic injection of 0.5 psi for 161 
5 sec., and separated at 30 kV. The drug substances were detected at 200 nm. 162 
Flow injection analysis coupled with electrospray ionization mass 163 
spectrometry 164 
The flow injection system consisted of a Dionex UltiMate 3000 WPS 3000 TSL autosampler, 165 
connected to a Thermo Scientific LTQ XL Linear Ion Trap Mass Spectrometer (all from 166 
Thermo Scientific, Sunnyvale, CA, USA). Data acquisition and processing were performed 167 
using Xcalibur version 2.1 software from Thermo Scientific. The flow rate of the running 168 
solution was set to 50 μL min-1 and consisted of 20mM HCOOH:acetonitrile (1:1), and the 169 
injection volume was set to 5 μL.  170 
An electrospray ionization (ESI) source operated in the positive ionization mode was used to 171 
interface the FIA and the MS. Analyses were performed with selected reaction monitoring 172 
(SRM) using He as a collision gas. The sheath gas was set to 25 units, auxiliary gas 5 units, 173 
capillary temperature 250°C, and the spray voltage to 4 kV. The quantifier SRM transitions 174 
were used to quantify the compounds while the qualifiers were used as confirmatory signals. 175 
The SRM transitions and collision energies are shown in Table 1. 176 
Ultra performance liquid chromatography (UPLC) combined with mass 177 
spectrometry 178 
A Waters Aquity UPLC-system was used for separation, applying an Aquity HSS T3-column 179 
(2.1 x 100 mm, 1.8 μm). The mobile phase consisted of 100% methanol (mobile phase A) and 180 
25 mmol/L formic acid (mobile phase B). The flow rate was 0.5 mL/min, and the following 181 
gradient was used. The initial composition 70% B and 30% A was held for 0.5 minutes, a 182 
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linear gradient up to 100% A in 0.5 minutes was then applied followed by 0.5 minutes at 100% 183 
A and return to initial conditions.  The total cycle time was 2 minutes. The column 184 
temperature was held at 65˚C, and the injection volume was 3 μL. Partial loop injection with a 185 
needle overfill flush of 3 μL was used, with each sample using 600 μL methanol:water (10:90) 186 
for “weak wash” and 200 μL methanol:water (90:10) for “strong wash”. 187 
A Waters Quattro Premier XE tandem mass spectrometer, equipped with a Z-spray 188 
electrospray interface, was used for detection. Positive ionization was performed in the 189 
multiple reaction monitoring (MRM) mode. One transition was used for each compound. The 190 
capillary voltage was set to 1.0 kV, the source block temperature was 120˚C, and the 191 
desolvation gas (nitrogen) was heated to 450˚C and delivered at a flow rate of 900 L/h. The 192 
cone gas (nitrogen) was set to 60 L/h, and the collision gas (argon) pressure was maintained at 193 
0.006 mbar in the collision cell. The UPLC conditions are presented in Table 2. System 194 
operation and data acquisition were controlled using Mass Lynx 4.1 software. Peak area was 195 
used for quantification using TargetLynx soft-ware. 196 
 197 
 198 
 199 
 200 
 201 
 202 
 203 
 204 
 205 
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Results and Discussions  206 
In parallel electromembrane extraction (Pa-EME) several electrical circuits are connected in 207 
parallel to a single power supply; from a theoretical point of view the voltage should be 208 
constant across each of the parallel-coupled wells. The eight well Pa-EME recently introduced 209 
was considered as the first attempt to increase the sample throughput with EME [9]. The 210 
robustness against small but deliberate variations in method parameters, focusing on RSD-211 
values and extraction recovery, was investigated in the present paper. The chemical structure, 212 
log P, and pKa-values of the three basic drug substances are included in Fig.2.  213 
Extraction recovery and robustness  214 
The first Pa-EME paper reported extraction recoveries in the range 15 to 33% for the four 215 
basic model analytes from untreated human plasma within 8 min of extraction [9]. An 216 
important observation from the experimental design in this paper was that both increased 217 
extraction voltage- and acceptor solution volume increased the extraction recovery. A recent 218 
publication also indicated that the volume of acceptor solution was an important parameter 219 
toward increased extraction recovery in electromembrane extraction [22]. However, due to 220 
safety considerations and technical challenges the upper limit for applied extraction voltage 221 
was set to 200 V in the first Pa-EME publication [9]. In the present investigation the strips of 222 
vials with the flat membrane was attached with glue to a 96-well rack for pipette tips to obtain 223 
a safer and more user-friendly Pa-EME configuration. This enabled 300 V to be used as 224 
extraction voltage. Additionally, the volume of the wells in the multi-well plate was increased 225 
and thus enabled an increased flexibility regarding acceptor solution volume. The 96-well Pa-226 
EME configuration is presented in Fig.1. 227 
This configuration was utilized to isolate three basic model substances from 20 mM formic 228 
acid. The sample solution volume was 240 μL, volume of 2-nitrophenyl octyl ether (NPOE) 229 
applied to the supporting material was 4 μL, the excess NPOE was gently removed after 30 230 
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seconds of drying, the volume of acceptor solution was 100 μL 20 mM formic acid, and 300V 231 
was applied for 10 min, and the Pa-EME system was agitated at 1050 rpm throughout 232 
extraction. This approach provided the following extraction recoveries: 99% (2%, RSD), 99% 233 
(2%, RSD), and 97% (3%, RSD), for amitriptyline, fluoxetine, and haloperidol, respectively; 234 
eight samples were processed in parallel and the RSD-values (%) are given in parentheses. 235 
The development of a more robust Pa-EME setup enabled an increased flexibility regarding 236 
magnitude of the applied electrical field and volume of the acceptor solution compared to the 237 
first Pa-EME publication, and this enabled exhaustive extraction. 238 
Although the first Pa-EME setup reported interesting findings regarding sample throughput 239 
and reproducibility a question about the robustness was raised after completing that paper. 240 
The purpose of the present investigation was to examine if a collapse in a single or multiple 241 
wells affected the extraction performance, and also how the extraction performance was 242 
affected by small, but deliberate variations in method parameters. 243 
In a parallel coupled configuration with direct current, the voltage in each circuit would be 244 
equal; however the current would be dependent on the resistance in each circuit. The total 245 
current in the system would be the sum of the current in each of the circuits. In EME the 246 
resistance is the organic liquid sustained in the pores of the supporting material; this 247 
resistance is controlled by addition of the same volume of organic liquid to each of the flat 248 
polypropylene membranes. If every circuit in the Pa-EME remains intact throughout 249 
extraction, the total current could be calculated by adding the current across each circuit; the 250 
voltage would consequently be constant. In the Pa-EME setup a perforation in one or several 251 
of the circuits would increase the total current in the system due to the elimination of the 252 
resistance in the circuit or circuits. In order to investigate this 240 μL 20 mM formic acid 253 
spiked with the three basic model substances was added to each of the eight wells, 4 μL 254 
NPOE was added to the supporting material, and the eight acceptor compartments were filled 255 
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with 100 μL 20 mM formic acid, 100 V was applied for 10 min, and the Pa-EME setup was 256 
subjected to an agitation rate at 900 rpm throughout extraction. The same procedure was 257 
utilized in another experiment; however, in the latter experiment the membranes in two of the 258 
wells were punctured. The punctured membranes resulted in an increase in the total current 259 
and subsequent electrolysis in the perforated wells. The extraction performance in both 260 
experiments was compared in terms of extraction recovery and reproducibility; the results are 261 
presented in Table 3. The extraction performance was unaffected in the non-punctured wells 262 
by the collapse in two of the extraction compartments. The same approach was used to 263 
investigate the impact of perforation of two sample compartments with undiluted human 264 
plasma as sample matrix. This experiment reported similar results and demonstrated that the 265 
Pa-EME setup was unaffected by small, but deliberate variations in method parameters also 266 
with human plasma as sample matrix as presented in Table 3.  267 
In another experiment the aim was to investigate the robustness of Pa-EME by extraction of 268 
eight human plasma samples, eight human urine samples, and eight water samples 269 
simultaneously. All samples were spiked with amitriptyline, fluoxetine, and haloperidol. In 270 
total 24 samples were processed in parallel, and 100 V was the magnitude of the applied 271 
electrical field with NPOE as organic liquid in the SLM. After 1 min of extraction the power 272 
supply was turned off and the SLM in several wells were perforated with a pipette tip. 273 
Thereafter, the power supply was turned on and the extraction was continued for another 6 274 
min. The perforation of some of the SLMs increased the total current significantly and caused 275 
extensive bubble formation in the associated wells. However, the extraction recoveries and 276 
the repeatability in the intact wells were unaffected by the perforations and demonstrated that 277 
even though some of the extractions failed all the remaining extracts were unaffected. This 278 
experiment demonstrated the robustness of Pa-EME and the data are presented in Table 4.  279 
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Sample throughput and effect of the electrical field 280 
In a next series of experiments the total number of samples processed in parallel was 281 
increased from 24 and both the extraction recovery and the repeatability were investigated. In 282 
this experiment isopropyl nitrobenzene (IPNB) in combination with low voltage (20 V) was 283 
selected as the organic liquid sustained in the pores of the supporting material and applied 284 
voltage, respectively. The choice of using IPNB in combination with low voltage was made 285 
essentially due to safety considerations regarding the magnitude of the applied electrical field 286 
and experiences with this particular combination in the HF-EME configuration [23]. The 287 
donor- and acceptor solution was 240 μL 20 mM formic acid spiked with amitriptyline, 288 
fluoxetine, and haloperidol- and 100 μL 20 mM formic acid, respectively. The volume of 289 
IPNB applied to the supporting material was 4 μL and the extraction was continued for 10 290 
min on a shaking board at 1050 rpm.  291 
In the first experiment a single sample was processed per time (n=4) and provided extraction 292 
recoveries in the range from 82 to 85% with RSD values in the range 13 to 16% as presented 293 
in Fig.3. Both with eight-, 68- and 96-well setup, and the extraction recoveries were similar to 294 
the extraction recoveries reported by processing one sample per time. The results are 295 
presented in Fig.3. The extraction performance was clearly unaffected by the total number of 296 
samples processed in parallel. This series of experiments demonstrated the potential 297 
concerning sample throughput with electromembrane extraction; in the most extreme 298 
experiment amitriptyline, fluoxetine, and haloperidol was isolated from 96 different samples 299 
and into LC-MS compatible extracts within 10 min. Interestingly, RSD-values were low, and 300 
with 96 samples the RSD-values were all below 6%.   301 
In a another experiment the impact of the applied electrical field was investigated; the 302 
extraction recoveries were examined with untreated human plasma at 0- and 250 V with 303 
NPOE as organic liquid in the SLM. Also the volume of acceptor solution was increased to 304 
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150 μL to facilitiate increased extraction recovery. This approach reported a two to eight fold 305 
increase in extraction recovery within 10 min of extraction by applying 250 V compared to 0 306 
V. The results are presented in Fig.4 and demonstrated the importance of the applied electrical 307 
field in EME. Although the pKa-values were 9.4, 9.8, and 8.3 for amitriptyline, fluoxetine, 308 
and haloperidol, respectively, and they were partially- or fully ionized at physiological pH 309 
(7.4) still the extraction recoveries were 51-, 10-, and 42% in the absence of an electrical field 310 
for amitriptyline, fluoxetine, and haloperidol, respectively. The acceptor solution volume 311 
could be an essential factor to the relatively high extraction recoveries even without an 312 
applied electrical field. 313 
Combination with high throughput analytical instrumentation 314 
The Pa-EME setup could potentially process 96 samples in parallel, and isolate the analytes of 315 
interest into aqueous extracts directly compatible with analytical instrumentation within 10 316 
min of extraction. However, this high throughput requires an analytical instrumentation with 317 
high capacity, meaning short analysis time per sample. An approach could be flow injection 318 
analysis (FIA), to omit the chromatographic separation. However, experiments demonstrated 319 
extensive ion suppression/enhancement due to altered ionization in the electrospray ionization 320 
source (ESI) when the substances were not separated prior to the MS analysis. Those FIA-321 
experiments are presented in Fig. 5a and emphasized the need for a chromatographic 322 
separation prior to MS-analysis.  323 
In another approach UPLC-MS/MS was selected as the analytical instrumentation to 324 
demonstrate the feasibility to analyze 96 EME-extracts within a relatively short time-frame 325 
with run-time of 2 min per extract. Three different samples, each spiked with amitriptyline, 326 
fluoxetine, and haloperidol at 50 ng mL-1, respectively, were processed with the Pa-EME 327 
configuration (n=4). In the next experiment a single sample spiked with the aforementioned 328 
model analytes at 50 ng mL-1 was processed with the Pa-EME setup (n=4). In the last 329 
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experiment a sample spiked with the same three basic model substances at 50 ng mL-1; 330 
additionally this sample was spiked with ibuprofen, nortriptyline, and paracetamol at high 331 
concentrations (1000 ng mL-1) before extraction in the Pa-EME setup (n=4). The aim of those 332 
experiments was to investigate if a chromatographic separation of only 2 min was acceptable 333 
to avoid matrix effects in the MS. The data obtained from those experiments are presented in 334 
Fig. 5b. The signal intensities for amitriptyline, fluoxetine, and haloperidol in the first 335 
experiment were compared to the signal intensities obtained for the same model substances in 336 
the presence of ibuprofen, nortriptyline, and paracetamol in the sample. A chromatogram of 337 
amitriptyline, fluoxetine, fluoxetine d-5, and haloperidol is included in Fig. 6. The signal 338 
intensities regarding amitriptyline, and fluoxetine were considered as unaffected by the 339 
presence of the other model substances. In the case of haloperidol a slight increase in signal 340 
intensity was observed; however taken the homebuilt Pa-EME configuration into 341 
consideration we considered this as acceptable. The combination of high-throughput Pa-EME 342 
with high throughput analytical instrumentation (UPLC-MS) was considered as a success.   343 
 344 
 345 
 346 
 347 
 348 
 349 
 350 
 351 
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Conclusions 352 
In the present investigation the robustness of parallel electromembrane extraction was 353 
investigated. The Pa-EME setup demonstrated to be robust against small but deliberate 354 
variations in method parameters. Different types of sample matrices were added to different 355 
wells and processed in parallel to investigate if the sample composition influenced the 356 
extraction performance. The extraction performance was found to be independent of the 357 
sample composition. Also the extraction recovery with different number of samples loaded 358 
into the multi-well plate was examined and the extraction recovery was found to be 359 
independent of the total number samples processed in parallel. In order to fully demonstrate 360 
the sample throughput, 96-samples were processed successfully in parallel within 10 min of 361 
extraction. Both the excellent sample clean-up provided and the high throughput provided 362 
with Pa-EME requested a very fast analytical technique. In a final series of experiments Pa-363 
EME was combined with flow injection analysis (FIA); however extensive matrix effects 364 
were observed without a chromatographic separation and consequently ultra performance 365 
liquid chromatography combined with mass spectrometry was selected as the analytical 366 
instrumentation to combine high-throughput sample preparation with high-throughput 367 
analytical instrumentation.   368 
The combination of a robust high-throughput electromembrane extraction setup with fast 369 
analytical instrumentation provides a powerful platform for analysis of small molecular drug 370 
substances from undiluted biological fluids.  371 
 372 
 373 
 374 
 375 
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Figure captions 376 
Figure 1. Picture of the 96-well Pa-EME setup utilized in this paper. 377 
Figure 2. Structure, log P, and pKa-value for amitriptyline, fluoxetine, and haloperidol. 378 
Figure 3. Extraction recovery (%) with 1, 68, and 96 samples in the Pa-EME setup.  379 
Donor solution: 240 μL, acceptor solution: 100 μL 20 mM HCOOH, SLM: 4 μL IPNB, 380 
extraction voltage: 20 V, extraction time: 10 min, agitation rate: 900 rpm  381 
Figure 4. Comparison of the extraction recovery with 0 V and 250 V. 382 
Donor solution: 240 μL, acceptor solution: 150 μL 20 mM HCOOH, SLM: 4 μL NPOE, 383 
extraction voltage: 0 V or 250 V, extraction time: 10 min, agitation rate: 900 rpm  384 
Figure 5. Flow injection analysis- (a) and ultra performance liquid chromatography (b) results. 385 
Donor solution: 240 μL, acceptor solution: 150 μL 20 mM HCOOH, SLM: 4 μL NPOE, 386 
extraction voltage: 200 V, extraction time: 10 min, agitation rate: 900 rpm  387 
Figure 6. UPLC-MS/MS chromatogram of haloperidol, fluoxetine d-5, fluoxetine, and 388 
amitriptyline. 389 
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Figure 1  402 
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Figure 2  414 
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Figure 3 428 
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Figure 4 444 
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Figure 6  467 
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Table 1. Flow injection analysis (FIA) conditions  477 
 478 
 SRM transitions Collision energy 
 Precursor Quantifier Qualifier  
Amitriptyline 278.15 233.1 104.9 35% 
Fluoxetine 310.11 147.99 - 29% 
Haloperidol 376.19 165.00 123.0, 358.20 29% 
25 
 Table 2. U
ltra perform
ance liquid chrom
atography (U
PLC
) conditions 
479 
 
M
RM
 transitions 
Cone Voltage (V) 
Collision Energy (eV) 
Am
itriptyline 
278.2>105.0 
32 
22 
Fluoxetine 
310.1>148.1 
20 
8 
Haloperidol 
376.3>165.0 
38 
24 
Fluoxetine d-5 
315.1>153.1 
20 
10 
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 Table 3. Perforation of tw
o w
ells w
ith undiluted hum
an plasm
a- and pure w
ater as sam
ples, respectively.  
490 
D
onor solution: 240 μL, acceptor solution: 100 μL 20 m
M
 H
C
O
O
H
, SLM
: 4 μL N
PO
E, extraction voltage: 100 V, extraction tim
e: 10 m
in, 
491 
agitation rate: 900 rpm
  
492 
 
493 
 
494 
 
495 
 
496 
 
497 
 
U
ndiluted hum
an plasm
a 
Pure w
ater sam
ples 
All w
ells intact 
Tw
o w
ells perforated 
All w
ells intact 
Tw
o w
ells perforated 
Am
itriptyline 
48%
 (10) 
49%
 (11) 
94%
 (11) 
94%
 (11) 
Fluoxetine 
38%
 (12) 
38%
 (11) 
75%
 (8) 
76%
 (9) 
Haloperidol 
53%
 (11) 
57%
 (11) 
90%
 (13) 
88%
 (14) 
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Table 4. Perforation of 7 wells with pure water samples, urine, and human plasma as sample 498 
matrices. 499 
Donor solution: 240 μL, acceptor solution: 100 μL 20 mM HCOOH, SLM: 4 μL NPOE, 500 
extraction voltage: 100 V, extraction time: 7 min, agitation rate: 900 rpm  501 
 502 
 Pure water samples Urine Plasma 
Amitryptiline 104% (14) 58% (12) 32% (15) 
Fluoxetine 87% (10) 76% (18) 26% (16) 
Haloperidol 87% (8) 82% (18) 33% (16) 
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